EP0743978A1 - Tablet with builder substances - Google Patents

Tablet with builder substances

Info

Publication number
EP0743978A1
EP0743978A1 EP95908245A EP95908245A EP0743978A1 EP 0743978 A1 EP0743978 A1 EP 0743978A1 EP 95908245 A EP95908245 A EP 95908245A EP 95908245 A EP95908245 A EP 95908245A EP 0743978 A1 EP0743978 A1 EP 0743978A1
Authority
EP
European Patent Office
Prior art keywords
weight
tablet
water
tablets
silicates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95908245A
Other languages
German (de)
French (fr)
Other versions
EP0743978B1 (en
Inventor
Wolfgang Seiter
Dieter Jung
Otto Koch
Birgit Stevermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to EP99115247A priority Critical patent/EP0965565A1/en
Publication of EP0743978A1 publication Critical patent/EP0743978A1/en
Application granted granted Critical
Publication of EP0743978B1 publication Critical patent/EP0743978B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047Detergents in the form of bars or tablets
    • C11D17/0065Solid detergents containing builders
    • C11D17/0073Tablets
    • C11D17/0078Multilayered tablets
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047Detergents in the form of bars or tablets
    • C11D17/0065Solid detergents containing builders
    • C11D17/0073Tablets
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/02Inorganic compounds ; Elemental compounds
    • C11D3/04Water-soluble compounds
    • C11D3/06Phosphates, including polyphosphates
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/02Inorganic compounds ; Elemental compounds
    • C11D3/12Water-insoluble compounds
    • C11D3/124Silicon containing, e.g. silica, silex, quartz or glass beads
    • C11D3/1246Silicates, e.g. diatomaceous earth
    • C11D3/1253Layer silicates, e.g. talcum, kaolin, clay, bentonite, smectite, montmorillonite, hectorite or attapulgite
    • C11D3/1273Crystalline layered silicates of type NaMeSixO2x+1YH2O
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/02Inorganic compounds ; Elemental compounds
    • C11D3/12Water-insoluble compounds
    • C11D3/124Silicon containing, e.g. silica, silex, quartz or glass beads
    • C11D3/1246Silicates, e.g. diatomaceous earth
    • C11D3/128Aluminium silicates, e.g. zeolites

Definitions

  • the invention relates to tablets, preferably washing or cleaning tablets, in particular detergent tablets or compounds in tabulated form for detergents which contain silicate builder substances.
  • Detergent tablets have a number of advantages over powdered detergents, such as simple dosing and low packaging volume requirements. Problems arise, however, in that relatively high compression pressures have to be used to achieve adequate dimensional stability and fracture resistance when pressing the powdery components. Because of the high degree of compaction, tablets of this type often have inadequate disintegration and dissolving properties during use. Further difficulties arise from the use of nonionic surfactants. According to the teaching of international patent application WO-A-90/02165, these problems can be solved by producing at least two granular components before the pressing, the total amount of the anionic surfactants in one component and the majority of the nonionic surfactants in the other component are included.
  • the component containing anionic surfactants preferably contains up to 20% by weight of anionic surfactants including the soaps, up to 30% by weight of water-containing zeolite, inorganic salts such as amorphous silicates and carbonates up to 40% by weight, polycarboxylates up to 5% by weight. , Sulfate up to 20 wt .-% and water, which is not bound to the zeolite, to a maximum of 5 wt .-%.
  • the last three statements apply equally to the second component, which also preferably contains up to 15% by weight of nonionic surfactants, up to 20% by weight of water-containing zeolite and up to 10% by weight of soda.
  • Other components which contain bleaching agents and / or enzymes, for example, are also optionally present.
  • Crystalline layered sodium silicates of the formula Na Si x ⁇ 2 ⁇ + ⁇ * yH2 ⁇ , where M is sodium or hydrogen, x is a number from 1.9 to 4 and y is a number from 0 to 20 and are preferred values for x 2, 3 or 4 , can substitute phosphates and zeolites.
  • Such crystalline layered silicates are described, for example, in the European patent application EP-A-0 164 514.
  • Preferred crystalline layered silicates are those in which M represents sodium and x assumes the values 2 or 3.
  • 'sodium disilicates Na2Si2 ⁇ s * yH2 ⁇ are both .beta.- and ⁇ preferred, with beta-sodium disilicate being er ⁇ hold, for example, by the method described in International Patent Application W0-A 91/08171.
  • ⁇ -sodium disilicate is commercially available under the name SKS 7 ( R )
  • fr-sodium disilicate is available under the name SKS ⁇ C *) (commercial products from Hoechst AG, Federal Republic of Germany).
  • These powders generally have a bulk density of less than 600 g / l and have a high proportion of fine particles, usually more than 30% by weight, with a particle size of less than 0.1 mm.
  • crystalline layered silicates suffer losses in their action as builders in the spray drying of detergent-containing or detergent-containing detergents, presumably caused by the partial destruction of their crystalline structure, they should preferably be incorporated into detergent or detergent by other process methods. However, due to their high proportion of fine grains and thus their dusty structure, these powders are also not suitable for serving as an additive component to other granular constituents of detergents or cleaning agents. When granulating crystalline layered sodium silicates, it should be noted that the strong abrasive properties of these silicates can damage the apparatus.
  • Amorphous alkali metal silicates in particular those with a molar M2 ⁇ : Si ⁇ 2 ⁇ ratio of 1: 1.9 to 1: 4.0, where M preferably stands for sodium and / or potassium, can generally be spray-dried, but the skilled worker knows that the spray drying of slurries which also contain zeolite in addition to the amorphous silicates leads to negative interactions, which reduces the exchange capacity of the zeolite. is set and can deposit deposits that are difficult to remove on the laundry.
  • Granules which have a high proportion of amorphous silicates or pure spray-dried or granulated amorphous silicates, on the other hand, are hygroscopic, so that they have to be specially protected against the ingress of atmospheric moisture during storage.
  • a further object of the invention was to offer builder forms containing builder substance which are sufficiently soluble or dispersible for the intended purpose.
  • This object was achieved in that an offer form with a relatively small specific surface was chosen, which can be produced with little water.
  • the invention accordingly relates to a tablet containing builder substances, this tablet containing amorphous, partially crystalline and / or crystalline layered sodium silicates of the formula Na2Si x ⁇ 2 ⁇ + ⁇ * yH2 ⁇ in amounts of 2 to 100% by weight and x containing a number of 1, 9 to 4 and y is a number from 0 to 20 and are preferred values for x 2, 3 or 4, with the proviso that the tablet contains water only in the amounts that the maximum theoretical water binding capacity of the ingredients is not exceeded.
  • the maximum theoretical water binding capacity can be determined in the manner described below.
  • Some components of the tablets form stable hydrates at an assumed storage temperature of 15 to 45 ° C. This applies, for example, to zeolite.
  • constituents such as sodium sulfate and polymeric polycarboxylates are counted as anhydrous substances, although it is known that these are generally present in hydrated form in granules.
  • Crystalline layered sodium silicates are also counted anhydrous, while amorphous sodium silicates for example, can have a water content of up to about 22% by weight.
  • the sum of the crystal water proportions from the stable hydrates gives the maximum theoretical water content of the tablet according to the invention. It may even be preferred that the tablet is in over-dried form, that is to say contains less water than corresponds to the maximum theoretical water-binding capacity or can be absorbed by the tablet ingredients in a stable manner.
  • the tablets can be produced in such a way that the amorphous, partially crystalline and / or crystalline layered sodium silicates and, if appropriate, all other constituents are mixed with one another in a mixer and the mixture by means of conventional tablet presses, for example eccentric presses, hydraulic presses or rotary presses with pressing pressures Range from 1 to 300 bar, advantageously in the range from about 5 to 200 bar and in particular between 10 and 150 bar.
  • the compression is preferably carried out without the addition of water.
  • the premixes intended for compression are produced by mixing the individual ingredients, which are present at least in part in pre-assembled form as a granular compound.
  • the pressing tools are made of high-strength material.
  • a tablet produced in this way preferably has a weight of 10 to 120 g, in particular 20 to 100 g, the diameter of the tablets usually being less than 100 mm .
  • Preferred detergent tablets have a maximum diameter of 80 mm and in particular from 30 to 80 mm.
  • These tablets preferably have a weight of 10 to 40 g, with diameters of 20 to 50 mm being preferred.
  • the diameter / height ratio of the tablets should be optimized in such a way that the least possible abrasion on the vertical walls of the tabletting apparatus (high diameter / low height) with sufficient stability and a surface that is not too large (small diameter / large) Height) is guaranteed.
  • Preferred diameter / height ratios of the cylindrical compacts are approximately 0.5: 1 to 10: 1, in particular 1: 1 to 8: 1.
  • the content of the tablets in amorphous, partially crystalline and / or crystalline layered sodium silicates can vary within a wide range. Which quantity ranges are actually used depends on the area of application in which this tablet is to be used. If such a tablet serves as a tableted washing or cleaning agent, preferred contents of amorphous, partially crystalline and / or crystalline layered sodium silicates are 5 to 60% by weight and in particular 10 to 40% by weight. However, if such tablets are only used as a compound and in particular as a water softening tablet, preferred contents of amorphous, partially crystalline and / or crystalline layered sodium silicates are 20 to 80% by weight and in particular 30 to 60% by weight. This also applies to bleaching tablets, which can be added to a wash liquor as bleach boosters.
  • the low-water to anhydrous disilicates are particularly preferred.
  • the preferred amorphous silicates primarily include the known spray-dried water glasses with a Na2 ⁇ : Si ⁇ 2 weight ratio of 1: 1.9 to 1: 3.35.
  • a preferred embodiment of silicates are silicate-carbonate compounds, for example those according to European patent applications EP-A-0488868 and EP-A-0561 565. Such compounds are known under the name Nabion l ⁇ ( R ) (commercial product from R ⁇ hne) -Poulenc) commercially available.
  • a particularly preferred embodiment of silicates is, however, those X-ray amorphous silicates as described in the older German patent application P 4400024.3.
  • tablets which contain either crystalline layered sodium silicates of the type specified or such X-ray amorphous silicates, or tablets which contain crystalline layered sodium silicates and X-ray amorphous silicates in a weight ratio of 10: 1 to 1:10.
  • Particularly preferred tablets are free of the usual amorphous silicates of the water glass type or contain these amorphous silicates of the water glass type only in combination with crystalline layered sodium silicates and / or X-ray amorphous silicates, the content of amorphous silicates being Water glass type advantageously does not exceed 20% by weight and in particular 15% by weight, based in each case on the total amount of silicates present in the tablet.
  • the tablets can contain up to 98% by weight of further ingredients of washing or cleaning agents. It is particularly preferred that the tablets have conventional tableting aids and / or disintegrants.
  • disintegrants which have a positive influence on the dissolving or disintegrating process in the aqueous application phase.
  • These disintegrants can be inorganic and / or organic in nature.
  • Typical inorganic-based disintegrants are, for example, swellable sheet silicates such as bentonites.
  • Organic disintegrants can Turscher or their derivatives based on starch or cellulose.
  • crosslinked potato starch for example, crosslinked potato starch, microcrystalline cellulose powder, but in particular also conventional ingredients of washing or cleaning agents such as the salts of polymeric polyacrylates or polyethacrylates, for example those with a low relative molecular weight between 1000 and 5000, but also methyl celluloses and / or hydroxypropyl celluloses or methyl hydroxypropyl celluloses.
  • acetates or percarbonates are preferably used in tablets containing bleach or directly in the bleaching tablets. It is customary to use disintegrants of this type in amounts of up to about 15% by weight, based on the tablet. Due to the use of water-soluble silicates, it is sufficient in most cases for the tablets according to the invention to use the disintegrants in amounts of well below 10% by weight, preferably in amounts of up to 5% by weight and in particular even less.
  • disintegrants in amounts of well below 10% by weight, preferably in amounts of up to 5% by weight and in particular even less.
  • amounts of around 1% by weight generally lead to very good results.
  • tabletting aids ensure better cohesion of the individual powdery or granular constituents and thus contribute to the stability of the tablet.
  • disintegrants which also serve as tablet auxiliaries or binders. These include, for example, starch, starch and cellulose derivatives, but also gelatin and polyvinyl pyrrolidone.
  • Other preferred binders are, for example, liquid to pasty nonionic surfactants which are liquid at the processing temperature.
  • the disintegrants and tableting aids are preferably used in dry form or in a form dissolved or suspended in nonionic surfactant.
  • An aqueous form of use is less preferred because water may only be added during the process in such quantities that the maximum theoretical water-binding capacity of the tablet ingredients is not exceeded. In a particularly preferred embodiment of the invention, therefore, no ingredient is in the form of an aqueous solution or suspension used and the pressing is carried out without the addition of water.
  • the tablets contain in particular further customary builder substances.
  • These include inorganic builder substances such as zeolite and / or phosphates or organic builder substances such as polycarboxylates and / or polymeric polycarboxylates.
  • Tablets are preferred which contain 0.5 to 98% by weight of water-containing zeolite and / or phosphates, the phosphate content preferably being at most 50% by weight and in particular at most 30% by weight ⁇ is limited.
  • a water softening tablet which is a preferred embodiment of the invention, 0 to 80% by weight, preferably 5 to 80% by weight and in particular 10 to 60% by weight of water-containing zeolite and / or phosphate present.
  • Bleaching tablets are preferably free of zeolite in order to exclude negative interactions, but may optionally contain phosphates.
  • the fine crystalline, synthetic and bound water containing zeolite used is preferably zeolite NaA in detergent quality.
  • zeolite NaX, zeolite P and mixtures of A, X or P are also suitable.
  • the zeolite can be used either as a spray-dried powder or as a granular compound which, for example, contains up to about 50% by weight of other constituents such as nonionic surfactants and cellulose ethers and / or contains polymeric polycarboxylates.
  • Suitable powdered zeolites have an average particle size of less than 10 ⁇ (volume distribution; measurement method: Coulter counter) and preferably contain 18 to 22% by weight, in particular 20 to 22% by weight, of bound water.
  • the tablets contain 0.5 to 50% by weight of organic builder substances such as polycarboxylates and / or polymeric polycarboxylates, but also their acids.
  • Water softening tablets preferably contain 0 to 50% by weight, in particular 0.5 to 30% by weight and advantageously 2 to 20% by weight of polycarboxylates and additionally preferably 0 to 15% by weight, in particular 0.5 to 12th % By weight and advantageously 1 to 10% by weight of polymeric polycarboxylates.
  • the polycarboxylic acids or the polycarboxylates include, in particular, the polycarboxylic acids used in the form of their sodium salts, such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids and mixtures thereof.
  • Suitable polymeric polycarboxylates are, for example, the sodium salts of polyacrylic acid or polymethacrylic acid, for example those with a relative molecular weight of 800 to 150,000 (based on acid).
  • Suitable copolymeric polycarboxylates are, in particular, those of acrylic acid with methacrylic acid and of acrylic acid or methacrylic acid with maleic acid.
  • Copolymers of acrylic acid with maleic acid which contain 50 to 90% by weight of acrylic acid and 50 to 10% by weight of maleic acid have proven to be particularly suitable.
  • Their relative molecular weight, based on free acids, is generally from 5,000 to 200,000, preferably from 10,000 to 120,000 and in particular from 50,000 to 100,000.
  • Terpolymeric polycarboxylates are also particularly preferred, for example those which are salts of acrylic acid and of monomers Maleic acid and vinyl alcohol or vinyl alcohol derivatives (DE-A-4300772) or the monomers as salts of acrylic acid and 2-alkylallylsulfonic acid and sugar derivatives (DE-C-4221 381).
  • the (co) polymeric polycarboxylates are preferably used either as a powder or as a granular compound.
  • Suitable granular compounds are, for example, those known from international patent application WO-A-92/13937.
  • Suitable builder systems are oxidation products of carboxyl group-containing polyglucosans and / or their water-soluble salts, as described, for example, in international patent application WO-A-93/08251 or their production, for example, in international patent application WO-A-93 / 16110.
  • polyacetals which can be obtained by reacting dialdehydes with polyolcarboxylic acids which have 5 to 7 carbon atoms and at least 3 hydroxyl groups, for example as described in European patent application EP-A-0 280 223 .
  • Preferred polyacetals are derived from dialdehydes such as glyoxal, glutar aldehyde, terephthalaldehyde and mixtures thereof and from polyol carboxylic acids such as gluconic acid and / or glucoheptonic acid.
  • the tablets have up to 40% by weight of anionic surfactants and / or soaps.
  • anionic surfactants used are, for example, those of the sulfonate and sulfate types.
  • Preferred surfactants of the sulfonate type are Cg-Ci3-alkylbenzenesulfonates, olefin sulfonates, i.e. Mixtures of alkene and hydroxyalkanesulfonates and disulfonates, such as those obtained, for example, from Ci2-Ci8 monoolefins with a terminal or internal double bond by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acidic hydrolysis of the sulfonation products.
  • alkanesulfonates obtained from C 1 -C 8 -alkanes, for example by sulfochlorination or sulfoxidation with subsequent hydrolysis or neutralization.
  • esters of ⁇ -sulfo fatty acids e.g. the ⁇ -sulfonated methyl esters of hydrogenated coconut, palm kernel or Taig ⁇ fatty acids.
  • Suitable anionic surfactants are sulfonated fatty acid glycerol esters.
  • Fatty acid glycerol esters are to be understood as the mono-, di- and triesters as well as their mixtures, as they are in the production by esterification by a monoglycerol with 1 to 3 moles of fatty acid or in the transesterification of triglycerides with 0.3 to 2 moles of glycerol be preserved.
  • Preferred sulfated fatty acid glycerol esters are the sulfonation products of saturated fatty acids having 6 to 22 carbon atoms, for example capric acid, caprylic acid, capric acid, myristic acid, lauric acid, palmitic acid, stearic acid or behenic acid. If one starts from fats and oils, that is to say natural mixtures of different fatty acid glycerol esters, it is necessary to largely saturate the starting products with hydrogen in a manner known per se, ie to harden them to iodine numbers less than 5, advantageously less than 2.
  • Suitable feedstocks are palm oil, palm kernel oil, palm stearin, olive oil, turnip oil, coriander oil, sunflower oil, cottonseed oil, peanut oil, linseed oil, lard oil or lard. Due to their high natural content of saturated fatty acids, it has proven to be particularly advantageous to start from coconut oil, palm kernel oil or beef tallow.
  • the sulfonation of the saturated fatty acids with 6 to 22 carbon atoms or the mixtures of fatty acid glycerol esters with iodine numbers less than 5, which contain fatty acids with 6 to 22 carbon atoms, is preferably carried out by reaction with gaseous sulfur trioxide and subsequent neutralization with aqueous bases, such as it is specified in the international patent application WO-A-91/09009.
  • Alk (en) yl sulfates are the Schwefelklandester the C ⁇ -cis-fatty alcohols are, for example, from coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl ristyl-, cetyl or stearyl alcohol, or C ⁇ o-C2 ⁇ _ 0xoalkohole and have those Halbester secondary alcohols this chain length preferred. Also preferred are alk (en) yl sulfates of the chain length mentioned which contain a synthetic, petrochemical-based straight-chain alkyl radical which have a degradation behavior analogous to that of the corresponding compounds based on oleochemical raw materials.
  • C ⁇ 6-Ci8-alk (en) yl sulfates are particularly preferred for washing technology reasons. It can also be particularly advantageous, and particularly advantageous for machine washing agents, to use Ci6-Ci8-alk (en) yl sulfates in combination with lower melting anionic surfactants and in particular with those anionic surfactants which have a lower Krafft point and relatively low ones Washing temperatures of, for example, room temperature to 40 ° C. show a low tendency to crystallize.
  • the compositions therefore contain mixtures of short-chain and long-chain fatty alkyl sulfates, preferably mixtures of Ci2-Ci4-fatty alkyl sulfates or Ci2-Ci8-fatty alkyl sulfates with Ci6-Ci8 ⁇ fatty alkyl sulfates and in particular Ci2-Ci6-fatty alkyl sulfates with Ci6-Ci8 fatty alkyl sulfates.
  • not only saturated alkyl sulfates but also unsaturated alkenyl sulfates with an alkenyl chain length of preferably C 6 to C 22 are used.
  • mixtures of saturated, predominantly Ci6 sulfated Fatty alcohols and unsaturated, sulfated fatty alcohols consisting predominantly of CJS are preferred, for example those which are derived from solid or liquid fatty alcohol mixtures of the HD-Ocenol ( R ) type (commercial product of the applicant).
  • Weight ratios of alkyl sulfates to alkenyl sulfates of 10: 1 to 1: 2 and in particular of about 5: 1 to 1: 1 are preferred.
  • the sulfuric acid monoesters of the straight-chain or branched C7 ⁇ C2i alcohols ethoxylated with 1 to 6 moles of ethylene oxide such as 2-methyl-branched Cg-Cn alcohols with an average of 3.5 moles of ethylene oxide (EO) or C j 2 -Ci8 fatty alcohols with 2 to 4 EO are suitable. Because of their high foaming behavior, they are used in detergents only in relatively small amounts, for example in amounts of 1 to 5% by weight.
  • Preferred anionic surfactants are also the salts of alkylsulfosuccinic acid, which are also referred to as sulfosuccinates or as sulfosuccinic acid esters and which are monoesters and / or diesters of sulfosuccinic acid with alcohols, preferably fatty alcohols and in particular ethoxylated fatty alcohols.
  • Preferred sulfosuccinates contain Cs to Ci8 fatty alcohol residues or mixtures thereof.
  • Particularly preferred sulfosuccinates contain a fatty alcohol residue which is derived from ethoxylated fatty alcohols which, viewed in isolation, are nonionic surfactants (for a description, see below).
  • sulfosuccinates the fatty alcohol residues of which are derived from ethoxylated fatty alcohols with a narrow homolog distribution, are particularly preferred. It is also possible to use alk (en) ylsuccinic acid with preferably 8 to 18 carbon atoms in the alk (en) yl chain or salts thereof.
  • Preferred anionic surfactant mixtures contain combinations of alk (en) yl sulfates, in particular mixtures of saturated and unsaturated fatty alk (en) yl sulfates, and alkylbenzenesulfonates, sulfated fatty acid glycerol esters and / or sulfofatty acid esters.
  • mixtures are preferred which contain alk (en) yl sulfates and alkylbenzenesulfonates, alk (en) yl sulfates and methyl ⁇ -sulfofatty acid and / or sulfated fatty acid glycerol esters as anionic surfactants.
  • Suitable anionic surfactants are, in particular, soaps, preferably in amounts of 0.1 to 5% by weight.
  • saturated fatty acid soaps are suitable, such as the salts of lauric acid, myristic acid, palmitic acid or stearic acid, and in particular soap mixtures derived from natural fatty acids, for example coconut, palm kernel or tallow fatty acids.
  • soap mixtures are preferred which are composed of 50 to 100% by weight saturated C12-C24 fatty acid soaps and 0 to 50% by weight oleic acid soap.
  • the anionic surfactants and soaps can be present in the form of their sodium, potassium or ammonium salts and as soluble salts of organic bases, such as mono-, di- or triethanolamine.
  • the anionic surfactants are preferably in the form of their sodium or potassium salts, in particular in the form of the sodium salts.
  • the nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, in particular primary alcohols having preferably 8 to 18 carbon atoms and an average of 1 to 12 moles of ethylene oxide (E0) per mole of alcohol in which the alcohol radical has a methyl or linear branching, preferably in the 2-position may be or may contain linear and methyl-branched radicals in the mixture, as are usually present in oxo alcohol radicals.
  • alcohol ethoxylates with linear residues of alcohols of native origin with 12 to 18 carbon atoms, for example from coconut, palm, tallow fat or oleyl alcohol, and an average of 2 to 8 E0 per mole of alcohol are particularly preferred.
  • the preferred ethoxylated alcohols include, for example, Ci2-Ci4 alcohols with 3 E0 or 4 E0, Cg-Cn alcohol with 7 E0, Ci3-Ci5 alcohols with 3 E0, 5 E0, 7 E0 or 8 E0, Ci2-Ci8- Alcohols with 3 E0, 5 E0 or 7 E0 and mixtures of these, such as mixtures of C12-Ci4 alcohol with 3 E0 and Ci2-Ci8 alcohol with 5 E0.
  • the degrees of ethoxylation given represent statistical averages, which can be an integer or a fraction for a specific product.
  • Preferred alcohol ethoxylates have a narrow homolog distribution (narrow range ethoxylates, NRE).
  • fatty alcohols with more than 12 E0 for example those up to about 80 E0, can also be used. Examples of this are tallow fatty alcohol with 14 E0, 25 E0, 30 E0 or 40 E0.
  • alkyl glycosides of the general formula R0 (G) x in which R is a primary straight-chain or methyl-branched, in particular methyl-branched aliphatic radical having 8 to 22, preferably 12 to 18, C., can also be used as further nonionic surfactants -Atoms means and G is the symbol which stands for a glycose unit with 5 or 6 carbon atoms, preferably for glucose.
  • the degree of oligomerization x which indicates the distribution of monoglycosides and oligoglycosides, is any number between 1 and 10; x is preferably 1.2 to 1.4.
  • Nonionic surfactants of the amine oxide type for example N-cocoalkyl-N.N-dimethyla inoxide and N-tallow alkyl-N.N-dihydroxyethylamine oxide, and the fatty acid alkanolamides may also be suitable.
  • the amount of these non-ionic surfactants is preferably not more than that of the ethoxylated fatty alcohols, in particular not more than half of them.
  • Suitable surfactants are polyhydroxy fatty acid amides of the formula (I),
  • R 2 is C0 for an aliphatic acyl radical with 6 to 22 carbon atoms
  • R ⁇ for hydrogen, an alkyl or hydroxyalkyl radical with 1 to 4 carbon atoms
  • [Z] for a linear or branched polyhydroxyalkyl radical with 3 to 10 carbon atoms and 3 to 10 hydroxyl groups.
  • the tablets contain the nonionic surfactants in amounts of up to 20% by weight.
  • alkaline organic salts in water which are preferably up to 15% by weight in the tablets.
  • These inorganic alkaline salts include in particular bicarbonates, carbonates or mixtures thereof; Alkali carbonate and especially sodium carbonate are preferably used.
  • the tablets can furthermore contain inorganic salts which react neutral in water, preferably sulfates and chlorides, in particular in the form of their sodium and / or calcium salts. Their content in the tablets is preferably up to about 20% by weight.
  • a further embodiment of the invention relates to water softening tablets which are 0 to 30% by weight, but preferably 0.5 to 20% by weight and in particular 2 to 15% by weight, of the anionic surfactants, nonionic surfactants mentioned, alkaline or neutral reacting inorganic salts or mixtures of these.
  • Peroxy bleaching agents and bleach activators can be mentioned as further important ingredients of tablets.
  • sodium perborate tetrahydrate and sodium perborate monohydrate are of particular importance.
  • Further usable bleaching agents are, for example, sodium percarbonate, peroxypyrophosphates, citrate perhydrates and H2O2-providing peracidic salts or peracids, such as perbenzoates, peroxophthalates, diperazelaic acid or diperdodecanedioic acid.
  • Peroxy bleaching agents which deliver 10 to 20% active oxygen per mole of component are particularly preferred.
  • the bleaching agent content of the tablets is preferably 15 to 60% by weight and in particular 10 to 50% by weight, advantageously using perborate monohydrate.
  • bleach activators can be incorporated into the preparations.
  • N-acyl or O-acyl compounds which form organic peracids with H2O2, preferably N, N'-tetraacylated diamines, furthermore carboxylic acid anhydrides and esters of polyols such as glucose sepentaacetate.
  • Other known bleach activators are acetylated mixtures of sorbitol and mannitol, as described, for example, in European patent application EP-A-0 525 239.
  • the bleach activators contain bleach activators in the usual range, preferably between 1 and 10% by weight and in particular between 3 and 8% by weight.
  • bleach activators are N, N, N ', N'-tetraacetylethylene diamine in (TAED), 1,5-diacetyl-2,4-dioxo-hexahydro-1,3,5-triazine (DADHT) and acetylated sorbitol-mannitol mixtures (SORMAN).
  • TAED N, N, N ', N'-tetraacetylethylene diamine in
  • DADHT 1,5-diacetyl-2,4-dioxo-hexahydro-1,3,5-triazine
  • SORMAN acetylated sorbitol-mannitol mixtures
  • the bleach activators can in particular also be used in granular form as a compound in the pressing.
  • Bleaching detergent tablets preferably contain peroxy bleach in amounts of 5 to 30% by weight and in particular 10 to 25% by weight. Tablets which are used as bleaching tablets, ie as bleach boosters in addition to other detergent formulations, which may be in tablet form, preferably contain peroxy bleaches in amounts of 20 to 50% by weight and especially in amounts of 25 to 45% by weight. A content of percarbonate in amounts of 10 to 40% by weight can be particularly advantageous if additional peroxy bleaching agents are used in particular at low percarbonate contents below 20% by weight.
  • a preferred bleaching tablet is characterized in that it contains 20 to 80% by weight, preferably 30 to 60% by weight, of amorphous, partially crystalline and / or crystalline layered sodium likates of the formula given and 20 to 50, preferably 25 to 45% by weight peroxy bleach, but does not contain zeolite.
  • the tablets can also contain further ingredients of washing or cleaning agents. These include common soil release and soil repellent compounds, but also solubility improvers, graying inhibitors, foam inhibitors, optical brighteners, enzymes, fabric softening agents, and colorants and fragrances. Their content in the tablets according to the invention preferably does not exceed 10% by weight.
  • the agents can therefore also contain components which have a positive influence on the oil and fat washability from textiles. This effect is particularly evident when a textile is contaminated which has already been washed several times beforehand with a detergent according to the invention which contains this oil- and fat-dissolving component.
  • the preferred oil- and fat-dissolving components include, for example, nonionic cellulose ethers such as methyl hydroxypropyl cellulose with a proportion of methoxyl groups of 15 to 30% by weight and of hydroxypropoxyl groups of 1 to 15% by weight, based in each case the nonionic cellulose ether, and the polymers of phthalic acid and / or the known from the prior art Therephthalic acid or its derivatives, in particular polymers of ethylene terephthalates and / or polyethylene glycol terephthalates.
  • the agents can also contain constituents which have a positive influence on the solubility of individual constituents of the tablets and thus also on the dissolution speed of the tablet itself.
  • the preferred additional components used include, in particular, polyethylene glycols with a relative molecular weight of between 200 and 4000.
  • Suitable foam inhibitors are, for example, soaps of natural or synthetic origin, which have a high proportion of Ci8 ⁇ C24 fatty acids.
  • Suitable non-surfactant-like foam inhibitors are, for example, organopolysiloxanes and their mixtures with microfine, optionally silanized silica, and paraffins, waxes, microcrystalline waxes and their mixtures with silanized silica or bistearylethylenediamide. Mixtures of different foam inhibitors are also used with advantages, e.g. those made of silicones, paraffins or waxes.
  • the foam inhibitors, in particular silicone or paraffin-containing foam inhibitors are preferably bound to a granular, water-soluble or dispersible carrier substance. Mixtures of paraffins and bistearylethylenediamides are particularly preferred.
  • Suitable enzymes are those from the class of proteases, lipases, amylases, cellulases or mixtures thereof. Enzymes obtained from bacterial strains or fungi such as Bacillus subtilis, Bacillus licheniformis and Streptomyces griseus are particularly suitable. Proteases of the subtilisin type and in particular proteases which are obtained from Bacillus lentus are preferably used.
  • enzyme mixtures for example of protease and aylase or protease and lipase or protease and cellulase or of cellulase and lipase or of protease, amylase and lipase or protease, lipase and cellulase, but in particular mixtures containing cellulase .
  • Peroxi- In some cases, these or oxidases have proven to be suitable.
  • the enzymes can be adsorbed on carriers and / or embedded in coating substances in order to protect them against premature decomposition.
  • the proportion of the enzymes, enzyme mixtures or enzyme granules can be, for example, about 0.1 to 5% by weight, preferably 0.1 to about 2% by weight.
  • the salts of polyphosphonic acids in particular l-hydroxyethane-l, l-diphosphonic acid (HEDP), diethylenetriaminepentamethylenephosphonic acid (DETPMP) or ethylenediaminetetramethylenephosphonic acid are suitable as stabilizers, in particular for per compounds and enzymes.
  • Graying inhibitors have the task of keeping the dirt detached from the fiber suspended in the liquor and thus preventing graying.
  • Water-soluble colloids of mostly organic nature are suitable for this, for example the water-soluble salts of polymeric carboxylic acids, glue, gelatin, salts of ether carboxylic acids or ether sulfonic acids of starch or cellulose or salts of acidic sulfuric acid esters of cellulose or starch.
  • Water-soluble polyamides containing acidic groups are also suitable for this purpose. Soluble starch preparations and starch products other than those mentioned above can also be used, e.g. degraded starch, aldehyde starches, etc.
  • Polyvinylpyrrolidone can also be used.
  • cellulose ethers such as carboxymethyl cellulose (sodium salt), methyl cellulose, hydroxyalkyl cellulose and mixed ethers, such as methyl hydroxyethyl cellulose, methyl hydroxypropyl cellulose, methyl carboxymethyl cellulose and mixtures thereof, and also polyvinylpyrrolidone, for example in amounts of 0.1 to 5% by weight , based on the funds used.
  • the agents can contain derivatives of diaminostilbenedisulfonic acid or its alkali metal salts. Suitable are, for example, salts of 4,4'-bis (2-anilino-4-morpholino-l, 3,5-triazinyl-6-amino) stilbene-2,2'-disulfonic acid or compounds of the same structure which contain an replace the morpholino group with a diethanolamino group, a methylamino group, an anilino group or a 2-methoxyethylamino group.
  • Brighteners of the substituted diphenylstyryl type may also be present, for example the alkali salts of 4,4'-bis (2-sulfostyryl) diphenyl, 4,4'-bis (4-chloro-3-sulfostyryl) diphenyl 1 or 4- (4-chlorostyryl) -4 '- (2- sulfostyryl) diphenyls. Mixtures of the aforementioned brighteners can also be used.
  • the tablets according to the invention can consist of several sub-components, as described in patent application WO-A-90/02165. So it is preferred that the tablets are produced by mixing at least 2 previously prepared powdery to granular components and then compressing this mixture, the total amount of anionic surfactants in one component and 75 to 100% by weight in the other component. -% of the total amount of nonionic surfactants is included.
  • Other subcomponents can also be used to produce the tablets, these can in particular contain bleaching agents and / or bleach activators or, for example, also enzymes, defoamers and fragrances.
  • the various components are not pressed into a uniform tablet, but that tablets are obtained which have several layers, that is to say at least 2 layers. It is also possible for these different layers to have different dissolution rates. This can result in advantageous application properties of the tablets. If, for example, components are contained in the tablets which mutually influence one another negatively, it is possible to integrate one component in the rapidly soluble layer and to incorporate the other component in a more slowly soluble layer, so that the first Component has already reacted when the second goes into solution.
  • a tablet consists of at least three layers, that is to say two outer and at least one inner layer, wherein at least one of the inner layers contains a peroxy bleach, but the two outer layers are free of peroxy bleach ⁇ are medium.
  • peroxy bleaching agents and any bleach activators and / or enzymes that may be present in one tablet.
  • Such multilayer tablets have the advantage that they not only have a dispenser or can be inserted via a metering device which is added to the wash liquor; rather, it is also possible in such cases to put the tablet in direct contact with the textiles in the machine without fear of bleaching and the like.
  • a washing process is also claimed in which several, but at least two tablets with the same or different composition are used for a single wash cycle.
  • a combination of tablets according to the modular principle is possible.
  • a water softening tablet and / or a bleaching tablet can then be used.
  • the addition of a water softening tablet can be helpful in areas with very high water hardness in tap water, while the use of an additional bleaching tablet can be made dependent on the type of textiles to be washed and the stains.
  • the tablet (s) can also be positioned on the laundry in the washing machine directly at the beginning of the washing process by means of a dosing container. Since high concentrations of active substances can be present at the beginning of the washing process with little moisture, the formation of stains on the laundry (for example due to the action of bleach) cannot be ruled out. This "spotting effect" is avoided, for example, by designing the dosing container like a basket. In the interior of the basket there is a water-permeable sieve or net-like receptacle for the tablets. The outer basket prevents the molded body from lying directly on the textiles. It is preferred that the sieve-like or mesh-like receptacle is relatively narrow-meshed, so that fragments from the basket only pass into the wash liquor when their maximum particle diameter is significantly less than 10 mm and advantageously less than 5 mm . Examples
  • the tablets of the following examples were produced in such a way that the corresponding constituents were first mixed and then produced in a hydraulically operating press (company Kürschner, Federal Republic of Germany) at pressures in the range from about 10 to 150 bar.
  • Example 1 Detergent tablet without zeolite
  • the water came from the raw materials used and was not added.
  • the fatty alcohol sulfate was introduced into the mixture via a compound which had been prepared in accordance with the teaching of the German patent application DE-A-4127323.
  • the SKS-6 () was premixed with the nonionic surfactant and then added to the remaining ingredients.
  • One tablet was sufficient as the sole detergent for one wash cycle and had a weight of 80 g. It had a diameter of 38 mm and a height of 15 mm.
  • Example 2 Detergent tablet with zeolite
  • a tablet was produced from a mixture containing 8% by weight of Ci2-Ci8 fatty alcohol sulfate, 6% by weight of Ci2-Ci8 fatty alcohol with 5E0, 1% by weight of Ci2-Ci8 sodium fatty acid soap, 11.5% by weight % crystalline layered sodium disilicate (SKS-6 ( R ), commercial product of Hoechst AG, Federal Republic of Germany), 15% by weight zeolite (based on anhydrous active substance), 5 % By weight sodium carbonate, 0.5% by weight amorphous sodium silicate (Na2 ⁇ : Si ⁇ 2 1: 3.0), 9% by weight trisodium citrate dihydrate, 20% by weight sodium perborate tetrahydrate, 6% by weight one TAED granules, 1% by weight of a granular protease, 9% by weight sodium sulfate, 1% by weight methyl hydroxypropyl cellulose, 0.5% by weight carboxymethyl cellulose (CMC), 0.6% by weight bentonite, 0.15%
  • the water came from the raw materials used, in particular from the powdered zeolite used, and was not added.
  • the fatty alcohol sulfate was again introduced into the mixture via a compound which had been produced in accordance with the teaching of the German patent application DE-A-41 27 323.
  • the zeolite was used in the form of a spray-dried powder, the slurry to be spray-dried additionally containing small amounts of nonionic surfactant, CMC, sodium hydroxide solution and the bentonite and the remaining nonionic surfactant was additionally applied.
  • One tablet was sufficient as the sole detergent for one wash cycle and had a weight of 80 g. It had a diameter of 38 mm and a height of 15 mm.
  • a tablet was produced from a mixture which contained 5.7% by weight sodium carbonate, 67% by weight SKS- ⁇ ( R ), 1% by weight methylhydroxypropylcellulose, 16% by weight trisodium citrate dihydrate, 8 %
  • a terpolymeric salt of acrylic acid, maleic acid and vinyl alcohol prepared according to the teaching of German patent application P 4300 772.4 and subsequent spray drying of a 38% by weight aqueous solution, 0.72% by weight of water, which is obtained from the raw materials used and was not additionally added, and contained 0.5% by weight sodium sulfate and the rest of further salts from the raw materials.
  • the tablet had a diameter of 23 mm, a height of 10 mm and a weight of 20 g.
  • a tablet was made from a mixture containing 58% by weight
  • SKS-6 ( R ) 30% by weight perborate monohydrate, 10.5% by weight of a TAED granulate and 1% by weight of methyl hydroxypropyl cellulose.
  • the tablet had a diameter of 23 mm, a height of 10 mm and a weight of 20 g.
  • a tablet was produced from a mixture comprising 16.5% by weight of Ci2-Ci8 fatty alcohol sulfate, 12.4% by weight of Ci2-Ci8 fatty alcohol with 5 EO, 1.5% by weight of Ci2-Ci8- Sodium fatty acid soap, 12% by weight of crystalline layered sodium disilicate (SKS-6 ( R ), commercial product of Hoechst AG, Federal Republic of Germany), 20% by weight of zeolite (based on anhydrous active substance), 2% by weight % Sokalan CP ⁇ ( R ), 10% by weight sodium carbonate, 0.5% by weight amorphous sodium silicate (Na2 ⁇ : Si ⁇ 2 1: 3.0), 1.5% by weight of a granular protease, 10% by weight Sodium sulfate, 1% by weight methyl hydroxypropyl cellulose, 1% by weight carboxymethyl cellulose (CMC), 1.3% by weight bentonite, 0.7% by weight of a granular foam inhibitor based on silicone oil, 0.2% by weight perfume, 0
  • the water came from the raw materials used, in particular from the powdered zeolite used, and was not additionally added.
  • the fatty alcohol sulfate was again introduced into the mixture via a compound which had been prepared in accordance with the teaching of the German patent application DE-A-41 27323.
  • the zeolite was used in the form of a spray-dried powder, the slurry to be spray-dried additionally containing small amounts of Nioten sid, CMC, sodium hydroxide solution and the bentonite.
  • One tablet weighed 40 g. It had a diameter of 35 mm and a height of 10 mm.
  • Example 6 Modular system made of tablets

Abstract

Tablets contg. builder substances comprise 2-100 wt.% amorphous, partly crystalline and/or crystalline layered silicates of formula Na2SixO2x+1.yH2O (I), where x=1.9-4 and y=0-20. The water content of the tablets is no more than the maximum theoretical water-binding capacity of the tablet ingredients. Also claimed are: (1) a process for producing tablets as above where the premixes intended for pressing are prepd. by mixing the individual ingredients, at least some of which are pregranulated; (2) a wash process in which at least two tablets as above, with the same or different compsn., are used in a single wash cycle, pref. a base detergent tablet and a water-softening and/or bleaching tablet; and (3) a wash process in which at least one tablet as above is used in a single wash cycle, the tablet(s) being dispensed onto the wash in the washing machine right at the start of the wash cycle. Pref. detergent tablets comprise 5-60 (esp. 10-40)wt.% (I), 0.5-98 wt.% zeolite and/or phosphate (pref. less than 30 wt.% phosphate), up to 40 wt.% anionic surfactants and/or soaps, and up to 20 wt.% nonionic surfactants. Water-softening tablets comprise 20-80 (esp. 30-60)wt.% (I), 0-80 (esp. 10-60)wt.% zeolite and/or phosphate, 0-50 (esp. 2-20) wt.% polycarboxylate, 0-15 (esp. 1-10)wt.% polymeric polycarboxylate, and 0-30 (esp. 2-15)wt.% surfactants and salts. Bleaching tablets comprise 20-80 (esp. 30-60) wt.% (I) and 20-50 (esp. 25-45) wt.% peroxy bleach. (I) may be used together with amorphous silicates of water-glass type.

Description

"Tablette mit Buildersubstanzen" "Tablet with builder substances"
Die Erfindung betrifft Tabletten, vorzugsweise wasch- oder reinigungsak¬ tive Tabletten, insbesondere Waschmitteltabletten oder Compounds in tab¬ lettierter Form für Waschmittel, welche silikatische Buildersubstanzen enthalten.The invention relates to tablets, preferably washing or cleaning tablets, in particular detergent tablets or compounds in tabulated form for detergents which contain silicate builder substances.
Waschmitteltabletten besitzen gegenüber pulverförmigen Mitteln eine Reihe von Vorteilen, wie eine einfache Dosierung und geringer Bedarf an Verpak- kungsvolumen. Probleme ergeben sich jedoch dadurch, daß zur Erreichung einer hinreichenden Form- und Bruchbeständigkeit beim Verpressen der pul¬ verförmigen Bestandteile verhältnismäßig hohe Preßdrucke angewendet werden müssen. Aufgrund der starken Verdichtung weisen derartige Tabletten viel¬ fach unzureichende Zerfall- und Löseeigenschaften bei der Anwendung auf. Weitere Schwierigkeiten ergeben sich aus der Mitverwendung von nichtioni¬ schen Tensiden. Diese Probleme können nach der Lehre der internationalen Patentanmeldung WO-A-90/02165 dadurch gelöst werden, daß vor der Verpres- sung mindestens zwei granuläre Komponenten hergestellt werden, wobei die Gesamtmenge der Aniontenside in der einen Komponente und die Hauptmenge der nichtionischen Tenside in der anderen Komponente enthalten sind. Die aniontensidhaltige Komponente enthält dabei vorzugsweise bis zu 20 Gew.-% Aniontenside einschließlich der Seifen, bis zu 30 Gew.-% wasserhaltigen Zeolith, anorganische Salze wie amorphe Silikate und Carbonate bis 40 Gew.-%, Polycarboxylate bis zu 5 Gew.-%, Sulfat bis zu 20 Gew.-% sowie Wasser, das nicht an den Zeolith gebunden ist, zu maximal 5 Gew.-%. Die letzten drei Aussagen gelten gleichermaßen auch für die zweite Komponente, die außerdem vorzugsweise bis zu 15 Gew.-% nichtionische Tenside, bis zu 20 Gew.-% wasserhaltigen Zeolith sowie bis zu 10 Gew.-% Soda enthält. Wei¬ tere Komponenten, welche beispielsweise Bleichmittel und/oder Enzyme ent¬ halten, sind ebenfalls optional vorhanden.Detergent tablets have a number of advantages over powdered detergents, such as simple dosing and low packaging volume requirements. Problems arise, however, in that relatively high compression pressures have to be used to achieve adequate dimensional stability and fracture resistance when pressing the powdery components. Because of the high degree of compaction, tablets of this type often have inadequate disintegration and dissolving properties during use. Further difficulties arise from the use of nonionic surfactants. According to the teaching of international patent application WO-A-90/02165, these problems can be solved by producing at least two granular components before the pressing, the total amount of the anionic surfactants in one component and the majority of the nonionic surfactants in the other component are included. The component containing anionic surfactants preferably contains up to 20% by weight of anionic surfactants including the soaps, up to 30% by weight of water-containing zeolite, inorganic salts such as amorphous silicates and carbonates up to 40% by weight, polycarboxylates up to 5% by weight. , Sulfate up to 20 wt .-% and water, which is not bound to the zeolite, to a maximum of 5 wt .-%. The last three statements apply equally to the second component, which also preferably contains up to 15% by weight of nonionic surfactants, up to 20% by weight of water-containing zeolite and up to 10% by weight of soda. Other components, which contain bleaching agents and / or enzymes, for example, are also optionally present.
Kristalline schichtförmige Natriumsilikate der Formel Na Sixθ2χ+ι*yH2θ, wobei M Natrium oder Wasserstoff bedeutet, x eine Zahl von 1,9 bis 4 und y eine Zahl von 0 bis 20 ist und bevorzugte Werte für x 2, 3 oder 4 sind, können Phosphate und Zeolithe substituieren. Derartige kristalline Schichtsilikate werden beispielsweise in der europäischen Patentanmeldung EP-A-0 164 514 beschrieben. Bevorzugte kristalline Schichtsilikate sind solche, in denen M für Natrium steht und x die Werte 2 oder 3 annimmt. Insbesondere sind sowohl ß- als auch δ'-Natriumdisilikate Na2Si2θs*yH2θ bevorzugt, wobei ß-Natriumdisilikat beispielsweise nach dem Verfahren er¬ halten werden kann, das in der internationalen Patentanmeldung W0-A- 91/08171 beschrieben ist. ß-Natriumdisilikat ist unter der Bezeichnung SKS 7(R), fr-Natriumdisilikat ist unter der Bezeichnung SKS δC*) im Handel er¬ hältlich (Handelsprodukte der Hoechst AG, Bundesrepublik Deutschland). Diese Pulver weisen im allgemeinen ein Schüttgewicht unter 600 g/1 auf und besitzen hohe Feinkornanteile, üblicherweise mehr als 30 Gew.-%, mit einer Teilchengröße unterhalb 0,1 mm. Da kristalline Schichtsilikate bei der Sprühtrocknung Wasch- oder Reinigungsmittel-haltiger Slurries Verluste in ihrer Wirkung als Gerüststoffe, vermutlich hervorgerufen durch die par¬ tielle Zerstörung ihrer kristallinen Struktur, erleiden, sollten sie vor¬ zugsweise über andere Verfahrensmethoden in Wasch- oder Reinigungsmittel eingearbeitet werden. Aufgrund ihres hohen Feinkornanteils und damit ihrer staubigen Struktur sind diese Pulver jedoch auch nicht geeignet, als Zu- mischkomponente zu anderen granulären Bestandteilen von Wasch- oder Rei¬ nigungsmitteln zu dienen. Bei der Granulierung von kristallinen schicht- förmigen Natriumsilikaten ist zu beachten, daß aufgrund der starken abra- siven Eigenschaften dieser Silikate Apparateschäden auftreten können. Dies bedeutet einmal, daß die Verfahrenssicherheit gefährdet ist und zusätz¬ liche Kontrollen der Misch- und Granulierwerkzeuge erforderlich sind, aber auch, daß durch den Materialabrieb das silikatische Produkt mit Metallspu¬ ren, insbesondere mit Schwermetallspuren belastet sein kann. Aus ökolo¬ gischen Gründen ist es wünschenswert, die Kontaminierung des Endprodukts so gering wie möglich zu halten. Außerdem ist dem Fachmann bekannt, daß beispielsweise die Stabilität von Peroxybleichmitteln durch Schwermetalle negativ beeinflußt wird.Crystalline layered sodium silicates of the formula Na Si x θ2χ + ι * yH2θ, where M is sodium or hydrogen, x is a number from 1.9 to 4 and y is a number from 0 to 20 and are preferred values for x 2, 3 or 4 , can substitute phosphates and zeolites. Such crystalline layered silicates are described, for example, in the European patent application EP-A-0 164 514. Preferred crystalline layered silicates are those in which M represents sodium and x assumes the values 2 or 3. In particular, 'sodium disilicates Na2Si2θs * yH2θ are both .beta.- and δ preferred, with beta-sodium disilicate being er¬ hold, for example, by the method described in International Patent Application W0-A 91/08171. β-sodium disilicate is commercially available under the name SKS 7 ( R ), fr-sodium disilicate is available under the name SKS δC *) (commercial products from Hoechst AG, Federal Republic of Germany). These powders generally have a bulk density of less than 600 g / l and have a high proportion of fine particles, usually more than 30% by weight, with a particle size of less than 0.1 mm. Since crystalline layered silicates suffer losses in their action as builders in the spray drying of detergent-containing or detergent-containing detergents, presumably caused by the partial destruction of their crystalline structure, they should preferably be incorporated into detergent or detergent by other process methods. However, due to their high proportion of fine grains and thus their dusty structure, these powders are also not suitable for serving as an additive component to other granular constituents of detergents or cleaning agents. When granulating crystalline layered sodium silicates, it should be noted that the strong abrasive properties of these silicates can damage the apparatus. This means on the one hand that the safety of the process is endangered and additional checks of the mixing and granulating tools are necessary, but also that the silicatic product can be contaminated with traces of metal, in particular traces of heavy metals, due to the material abrasion. For ecological reasons, it is desirable to keep the contamination of the end product as low as possible. It is also known to the person skilled in the art that, for example, the stability of peroxy bleaching agents is adversely affected by heavy metals.
Amorphe Alkalimetallsilikate, insbesondere solche mit einem molaren M2θ:Siθ2~ erhältnis von 1:1,9 bis 1:4,0, wobei M vorzugsweise für Natrium und/oder Kalium steht, lassen sich zwar in der Regel sprühtrocknen, jedoch weiß der Fachmann, daß es bei der Sprühtrocknung von Aufschlämmungen, wel¬ che außer den amorphen Silikaten auch noch Zeolith enthalten, zu negativen Wechselwirkungen kommt, wodurch das Austauschvermögen des Zeoliths herab- gesetzt wird und auf dem Waschgut schwierig entfernbare Niederschläge ab¬ lagern können. Granulate, welche einen hohen Anteil an amorphen Silikaten aufweisen, bzw. reine sprühgetrocknete oder granulierte amorphe Silikate sind hingegen hygroskopisch, so daß sie bei der Lagerung speziell vor dem Zutritt von Luftfeuchtigkeit geschützt werden müssen.Amorphous alkali metal silicates, in particular those with a molar M2θ: Siθ2 ~ ratio of 1: 1.9 to 1: 4.0, where M preferably stands for sodium and / or potassium, can generally be spray-dried, but the skilled worker knows that the spray drying of slurries which also contain zeolite in addition to the amorphous silicates leads to negative interactions, which reduces the exchange capacity of the zeolite. is set and can deposit deposits that are difficult to remove on the laundry. Granules which have a high proportion of amorphous silicates or pure spray-dried or granulated amorphous silicates, on the other hand, are hygroscopic, so that they have to be specially protected against the ingress of atmospheric moisture during storage.
Es bestand also zum einen die Aufgabe, eine vorteilhafte Angebotsform für Produkte zu entwickeln, welche amorphe und/oder kristalline Silikate ent¬ halten. Dabei sollte sowohl die Verfahrenssicherheit als auch die Stabi¬ lität der gegebenenfalls sonstigen Bestandteile der Angebotsform erhöht werden. Zusätzlich sollten die Buildereigenschaften erhalten bleiben. Eine weitere Aufgabe der Erfindung bestand darin, Buildersubstanz-haltige An¬ gebotsformen anzubieten, die für den Bestimmungszweck ausreichend löslich bzw. dispergierbar sind.On the one hand, there was the task of developing an advantageous offer form for products which contain amorphous and / or crystalline silicates. Both the procedural security and the stability of any other components of the offer form should be increased. In addition, the builder properties should be retained. A further object of the invention was to offer builder forms containing builder substance which are sufficiently soluble or dispersible for the intended purpose.
Diese Aufgabe wurde dadurch gelöst, daß eine Angebotsform mit einer rela¬ tiv geringen spezifischen Oberfläche gewählt wurde, die wasserarm herge¬ stellt werden kann.This object was achieved in that an offer form with a relatively small specific surface was chosen, which can be produced with little water.
Gegenstand der Erfindung ist dementsprechend eine Tablette, enthaltend Buildersubstanzen, wobei diese Tablette amorphe, teilkristalline und/oder kristalline schichtförmige Natriumsilikate der Formel Na2Sixθ2χ+ι*yH2θ in Mengen von 2 bis 100 Gew.-% enthält und x eine Zahl von 1,9 bis 4 und y eine Zahl von 0 bis 20 ist und bevorzugte Werte für x 2, 3 oder 4 sind, mit der Maßgabe, daß die Tablette Wasser nur in den Mengen enthält, daß das maximale theoretische Wasserbindevermögen der Inhaltsstoffe nicht überschritten wird.The invention accordingly relates to a tablet containing builder substances, this tablet containing amorphous, partially crystalline and / or crystalline layered sodium silicates of the formula Na2Si x θ2χ + ι * yH2θ in amounts of 2 to 100% by weight and x containing a number of 1, 9 to 4 and y is a number from 0 to 20 and are preferred values for x 2, 3 or 4, with the proviso that the tablet contains water only in the amounts that the maximum theoretical water binding capacity of the ingredients is not exceeded.
Das maximale theoretische Wasserbindevermögen kann auf die nachfolgend beschriebene Art festgestellt werden. Einige Bestandteile der Tabletten bilden bei einer angenommenen Lagerungstemperatur von 15 bis 45 °C stabile Hydrate aus. Dies gilt z.B. für Zeolith. Bestandteile wie Natriumsulfat und polymere Polycarboxylate hingegen werden als wasserfreie Substanzen gerechnet, obwohl bekannt ist, daß diese in Granulaten in der Regel in hydratisierter Form vorliegen. Auch kristalline schichtförmige Natriumdi- silikate werden wasserfrei gerechnet, während amorphe Natriumsilikate bei- spielsweise einen Wassergehalt bis etwa 22 Gew.-% aufweisen können. Die Summe der Kristall-Wasseranteile aus den stabilen Hydraten ergibt den maximalen theoretischen Wassergehalt der erfindungsgemäßen Tablette. Dabei kann es sogar bevorzugt sein, daß die Tablette in übertrockneter Form vor¬ liegt, also weniger Wasser enthält, als dem maximalen theoretischen Was¬ serbindevermögen entspricht bzw. als von den Tabletteninhaltsstoffen sta¬ bil aufgenommen werden kann.The maximum theoretical water binding capacity can be determined in the manner described below. Some components of the tablets form stable hydrates at an assumed storage temperature of 15 to 45 ° C. This applies, for example, to zeolite. In contrast, constituents such as sodium sulfate and polymeric polycarboxylates are counted as anhydrous substances, although it is known that these are generally present in hydrated form in granules. Crystalline layered sodium silicates are also counted anhydrous, while amorphous sodium silicates for example, can have a water content of up to about 22% by weight. The sum of the crystal water proportions from the stable hydrates gives the maximum theoretical water content of the tablet according to the invention. It may even be preferred that the tablet is in over-dried form, that is to say contains less water than corresponds to the maximum theoretical water-binding capacity or can be absorbed by the tablet ingredients in a stable manner.
Dabei können die Tabletten so hergestellt werden, daß man die amorphen, teilkristallinen und/oder kristallinen schichtförmigen Natriumsilikate und gegebenenfalls alle anderen Bestandteile in einem Mischer miteinander ver¬ mischt und das Gemisch mittels herkömmlicher Tablettenpressen beispiels¬ weise Exzenterpressen, hydraulischen Pressen oder Rundlauferpressen mit Preßdrucken im Bereich von 1 bis 300 bar, vorteilhafterweise im Bereich von etwa 5 bis 200 bar und insbesondere zwischen 10 und 150 bar verpreßt. Vorzugsweise erfolgt die Verpressung dabei ohne die Zugabe von Wasser. In einer bevorzugten Ausführungsform der Erfindung werden die zur Verpressung vorgesehenen Vorgemische jedoch durch Vermischen der einzelnen Inhalts¬ stoffe, die wenigstens anteilsweise in vorkonfektionierter Form als granu¬ läres Compound vorliegen, hergestellt. Hierzu zählen beispielsweise wal- zenkompaktierte kristalline schichtförmige oder amorphe Natriumdisilikate, die gegebenenfalls mit flüssigen bis wachsartigen Komponenten, beispiels¬ weise nichtionischen Tensiden imprägniert wurden. Insbesondere wird hier¬ durch eine wasserfreie Vorkonfektionierung ermöglicht, welche besonders vorteilhaft ist. Man erhält so problemlos bruchfeste und dennoch unter Anwendungsbedigungen ausreichend schnell lösliche Tabletten mit guter Bruchfestigkeit. Die Preßbedingungen sind im jeweiligen Fall üblicherweise auf die Einstellung der gewünschten Löslichkeit der Tablette bei gleich¬ zeitig ausreichender Festigkeit bzw. Härte der Tablette zu optimieren. Dabei gilt in an sich bekannter Weise, daß höhere Preßdrucke eine Vermin¬ derung der Löslichkeit der Tablette bewirken. Bevorzugte Tabletten weisen eine Bruchfestigkeit von mindestens 55 N und insbesondere von mindestens 60 N auf. Es sind auch Tabletten mit Bruchfestigkeiten über 150 N möglich.The tablets can be produced in such a way that the amorphous, partially crystalline and / or crystalline layered sodium silicates and, if appropriate, all other constituents are mixed with one another in a mixer and the mixture by means of conventional tablet presses, for example eccentric presses, hydraulic presses or rotary presses with pressing pressures Range from 1 to 300 bar, advantageously in the range from about 5 to 200 bar and in particular between 10 and 150 bar. The compression is preferably carried out without the addition of water. In a preferred embodiment of the invention, however, the premixes intended for compression are produced by mixing the individual ingredients, which are present at least in part in pre-assembled form as a granular compound. These include, for example, roll-compacted, crystalline, layered or amorphous sodium disilicates, which have optionally been impregnated with liquid to wax-like components, for example nonionic surfactants. In particular, this enables water-free pre-assembly, which is particularly advantageous. In this way, break-proof tablets with good breaking strength that are sufficiently quickly soluble under application conditions are obtained without any problems. The pressing conditions in the respective case are usually to be optimized for the setting of the desired solubility of the tablet while at the same time having sufficient strength or hardness of the tablet. It applies in a manner known per se that higher compression pressures reduce the solubility of the tablet. Preferred tablets have a breaking strength of at least 55 N and in particular at least 60 N. Tablets with breaking strengths above 150 N are also possible.
Mit hartem Kunststoff beschichtete Werkzeuge lieferten, ebenso wie unbe¬ schichtete, Tabletten mit glatten Oberflächen, so daß in dem meisten Fäl- len auf eine Beschichtung der Stempel mit weichem Kunststoff verzichtet werden konnte. Allerdings ist es bevorzugt, daß die Preßwerkzeuge in hoch¬ festem Werkstoff gefertigt sind.Tools coated with hard plastic as well as uncoated delivered tablets with smooth surfaces, so that in most cases len the coating of the stamp with soft plastic could be dispensed with. However, it is preferred that the pressing tools are made of high-strength material.
Als Raumform kommen praktisch alle sinnvollen handhabbaren Ausgestaltungs¬ formen in Betracht, solange sie den Anforderungen entsprechen, daß der Kontakt zur Tablettierapparatur während des Herstellungsprozesses relativ gering ist. Bevorzugt sind hierbei zylinderförmige Ausgestaltungen mit ovalem oder kreisförmigem Querschnitt der unten angegebenen Art. Vorzugs¬ weise weist eine derart hergestellte Tablette ein Gewicht von 10 bis 120 g, insbesondere von 20 bis 100 g auf, wobei der Durchmesser der Tabletten üblicherweise kleiner als 100 mm ist. Bevorzugte Waschmitteltabletten wei¬ sen einen Durchmesser von maximal 80 mm und insbesondere von 30 bis 80 mm auf. Es ist jedoch auch möglich und insbesondere auch im Hinblick auf ver¬ besserte Löslichkeiten bevorzugt, mehrere, also mindestens 2 Tabletten mit gleicher oder unterschiedlicher Zusammensetzung einzusetzen. Diese Tablet¬ ten besitzen vorzugsweise ein Gewicht von 10 bis 40 g, wobei Durchmesser von 20 bis 50 mm bevorzugt sind. Das Durchmesser/Höhe-Verhältnis der Ta¬ bletten soll dahingehend optimiert sein, daß eine möglichst geringe Abrasion an den vertikalen Wänden der Tablettierapparatur (hoher Durchmes¬ ser/geringe Höhe) mit einer ausreichenden Stabilität und einer nicht zu großen Oberfläche (kleiner Durchmesser/große Höhe) gewährleistet ist. Be¬ vorzugte Durchmesser/Höhe-Verhältnisse der zylindrischen Preßlinge liegen bei etwa 0,5:1 bis 10:1, insbesondere bei 1:1 bis 8:1.Practically all sensible, manageable forms of configuration come into consideration as the spatial form, as long as they meet the requirements that the contact with the tableting apparatus during the manufacturing process is relatively low. Cylindrical configurations with an oval or circular cross section of the type specified below are preferred. A tablet produced in this way preferably has a weight of 10 to 120 g, in particular 20 to 100 g, the diameter of the tablets usually being less than 100 mm . Preferred detergent tablets have a maximum diameter of 80 mm and in particular from 30 to 80 mm. However, it is also possible, and particularly preferred with a view to improved solubilities, to use several, that is to say at least 2, tablets with the same or different compositions. These tablets preferably have a weight of 10 to 40 g, with diameters of 20 to 50 mm being preferred. The diameter / height ratio of the tablets should be optimized in such a way that the least possible abrasion on the vertical walls of the tabletting apparatus (high diameter / low height) with sufficient stability and a surface that is not too large (small diameter / large) Height) is guaranteed. Preferred diameter / height ratios of the cylindrical compacts are approximately 0.5: 1 to 10: 1, in particular 1: 1 to 8: 1.
Der Gehalt der Tabletten an amorphen, teilkristallinen und/oder kristal¬ linen schichtförmigen Natriumsilikaten kann in einem weiten Bereich vari¬ ieren. Welche Mengenbereiche nun tatsächlich eingesetzt werden, hängt von dem Einsatzgebiet ab, in dem diese Tablette eingesetzt werden soll. Dient eine derartige Tablette als tablettiertes Wasch- oder Reinigungsmittel, so liegen bevorzugte Gehalte an amorphen, teilkristallinen und/oder kristal¬ linen schichtförmigen Natriumsilikaten bei 5 bis 60 Gew.-% und insbeson¬ dere bei 10 bis 40 Gew.-%. Werden derartige Tabletten jedoch nur als Com¬ pound und insbesondere als Wasserenthärtungstablette eingesetzt, so liegen bevorzugte Gehalte an amorphen, teilkristallinen und/oder kristallinen schichtförmigen Natriumsilikaten bei 20 bis 80 Gew.-% und insbesondere bei 30 bis 60 Gew.-%. Dies gilt ebenso für bleichende Tabletten, die also als Bleichbooster zu einer Waschflotte hinzugegeben werden können.The content of the tablets in amorphous, partially crystalline and / or crystalline layered sodium silicates can vary within a wide range. Which quantity ranges are actually used depends on the area of application in which this tablet is to be used. If such a tablet serves as a tableted washing or cleaning agent, preferred contents of amorphous, partially crystalline and / or crystalline layered sodium silicates are 5 to 60% by weight and in particular 10 to 40% by weight. However, if such tablets are only used as a compound and in particular as a water softening tablet, preferred contents of amorphous, partially crystalline and / or crystalline layered sodium silicates are 20 to 80% by weight and in particular 30 to 60% by weight. This also applies to bleaching tablets, which can be added to a wash liquor as bleach boosters.
Von den kristallinen schichtförmigen Natriumsilikaten sind insbesondere die wasserarmen bis wasserfreien Disilikate bevorzugt. Zu den bevorzugten amorphen Silikaten zählen in erster Linie die bekannten sprühgetrockneten Wassergläser mit einem Gewichtsverhältnis Na2θ:Siθ2 von 1:1,9 bis 1:3,35. Eine bevorzugte Ausführungsform an Silikaten stellen Silikat-Carbonat-Co - pounds, beispielsweise solche gemäß den europäischen Patentanmeldungen EP-A-0488868 und EP-A-0561 565 dar. Derartige Compounds sind unter dem Namen Nabion lδ(R) (Handelsprodukt der Firma Rδhne-Poulenc) im Handel er¬ hältlich. Eine besonders bevorzugte Ausführungsform an Silikaten stellen jedoch auch solche röntgenamorphe Silikate dar, wie sie in der älteren deutschen Patentanmeldung P 4400024.3 beschrieben werden. Daher sind solche Tabletten bevorzugt, welche entweder kristalline schichtförmige Natriums likate der angegeben Art oder derartige röntgenamorphe Silikate enthalten, oder Tabletten, welche kristalline schichtförmige Natriumsi¬ likate und röntgenamorphe Silikate im Gewichtsverhältnis von 10:1 bis 1:10 enthalten. Insbesondere bevorzugte Tabletten sind dabei frei von üblichen amorphen Silikaten des Wasserglas-Typs oder enthalten diese amorphen Si¬ likate des Wasserglas-Typs nur in Kombination mit kristallinen schichtför¬ migen Natriums likaten und/oder röntgenamorphen Silikaten, wobei der Ge¬ halt an amorphen Silikaten des Wasserglas-Typs vorteilhafterweise 20 Gew.-% und insbesondere 15 Gew.-%, jeweils bezogen auf die Gesamtmenge der vorhandenen Silikate in der Tablette, nicht übersteigt.Of the crystalline layered sodium silicates, the low-water to anhydrous disilicates are particularly preferred. The preferred amorphous silicates primarily include the known spray-dried water glasses with a Na2θ: Siθ2 weight ratio of 1: 1.9 to 1: 3.35. A preferred embodiment of silicates are silicate-carbonate compounds, for example those according to European patent applications EP-A-0488868 and EP-A-0561 565. Such compounds are known under the name Nabion lδ ( R ) (commercial product from Rδhne) -Poulenc) commercially available. A particularly preferred embodiment of silicates is, however, those X-ray amorphous silicates as described in the older German patent application P 4400024.3. Therefore, tablets are preferred which contain either crystalline layered sodium silicates of the type specified or such X-ray amorphous silicates, or tablets which contain crystalline layered sodium silicates and X-ray amorphous silicates in a weight ratio of 10: 1 to 1:10. Particularly preferred tablets are free of the usual amorphous silicates of the water glass type or contain these amorphous silicates of the water glass type only in combination with crystalline layered sodium silicates and / or X-ray amorphous silicates, the content of amorphous silicates being Water glass type advantageously does not exceed 20% by weight and in particular 15% by weight, based in each case on the total amount of silicates present in the tablet.
Die Tabletten können bis zu 98 Gew.-% weitere Inhaltsstoffe von Wasch¬ oder Reinigungsmittel beeinhalten. Dabei ist es insbesondere bevorzugt, daß die Tabletten übliche Tablettierhilfsmittel und/oder Sprengmittel aufweisen.The tablets can contain up to 98% by weight of further ingredients of washing or cleaning agents. It is particularly preferred that the tablets have conventional tableting aids and / or disintegrants.
Als Sprengmittel werden Hilfsstoffe angesehen, welche den Lösungs- oder Zerfallsprozeß in der wäßrigen Anwendungsphase positiv beeinflussen. Diese Sprengmittel können anorganischer und/oder organischer Natur sein. Ty¬ pische Sprengmittel auf anorganischer Basis sind beispielsweise quellfä¬ hige Schichtsilikate wie Bentonite. Organische Sprengmittel können Na- turstoffe oder deren Derivate auf Basis der Stärke oder der Cellulose sein. Hier können beispielsweise vernetzte Kartoffelstärke, mikrokristal¬ line Cellulosepulver, insbesondere aber auch übliche Inhaltsstoffe von Wasch- oder Reinigungsmitteln wie die Salze von polymeren Polyacrylaten oder Poly ethacrylaten, beispielsweise solche mit einer niedrigen rela¬ tiven Molekülmasse zwischen 1000 und 5000, aber auch Methylcellulosen und/oder Hydroxypropylcellulosen bzw. Methylhydroxypropylce11ulosen ge¬ nannt werden.Auxiliaries are regarded as disintegrants which have a positive influence on the dissolving or disintegrating process in the aqueous application phase. These disintegrants can be inorganic and / or organic in nature. Typical inorganic-based disintegrants are, for example, swellable sheet silicates such as bentonites. Organic disintegrants can Turstoffe or their derivatives based on starch or cellulose. Here, for example, crosslinked potato starch, microcrystalline cellulose powder, but in particular also conventional ingredients of washing or cleaning agents such as the salts of polymeric polyacrylates or polyethacrylates, for example those with a low relative molecular weight between 1000 and 5000, but also methyl celluloses and / or hydroxypropyl celluloses or methyl hydroxypropyl celluloses.
Weitere Beispiele sind Acetate oder Percarbonate. Letztere werden vorzugs¬ weise in bleichmittelhaltigen Tabletten oder direkt in den Bleichtabletten eingesetzt. Es ist üblich, derartige Sprengmittel in Mengen von bis etwa 15 Gew.-%, bezogen auf die Tablette, einzusetzen. Aufgrund des Einsatzes von wasserlöslichen Silikaten genügt es bei den erfindungsgemäßen Tablet¬ ten in den meisten Fällen, die Sprengmittel in Mengen von weit unterhalb 10 Gew.-%, vorzugsweise in Mengen von bis zu 5 Gew.-% und insbesondere noch darunter einzusetzen. Beim Einsatz von Poly(meth)acrylaten und/oder nichtionischen Celluloseethern führen in der Regel schon Mengen um 1 Gew.-% zu sehr guten Ergebnissen.Other examples are acetates or percarbonates. The latter are preferably used in tablets containing bleach or directly in the bleaching tablets. It is customary to use disintegrants of this type in amounts of up to about 15% by weight, based on the tablet. Due to the use of water-soluble silicates, it is sufficient in most cases for the tablets according to the invention to use the disintegrants in amounts of well below 10% by weight, preferably in amounts of up to 5% by weight and in particular even less. When using poly (meth) acrylates and / or nonionic cellulose ethers, amounts of around 1% by weight generally lead to very good results.
Im Gegensatz zu den Sprengmitteln sorgen Tablettierhilfsmittel für einen besseren Zusammenhalt der einzelnen pulverförmigen oder granulären Be¬ standteile und tragen somit zur Stabilität der Tablette bei. Es gibt je¬ doch eine ganze Reihe von Sprengmitteln, die gleichzeitig auch als Tablet¬ tierhilfsmittel oder Bindemittel dienen. Zu diesen zählen beispielsweise Stärke, Stärke- und Cellulosederivate, aber auch Gelatine und Polyvinyl- pyrrolidon. Weitere bevorzugte Bindemittel sind beispielsweise bei der Verarbeitungstemperatur flüssige bis pastöse nichtionische Tenside.In contrast to the disintegrants, tabletting aids ensure better cohesion of the individual powdery or granular constituents and thus contribute to the stability of the tablet. However, there is a whole range of disintegrants which also serve as tablet auxiliaries or binders. These include, for example, starch, starch and cellulose derivatives, but also gelatin and polyvinyl pyrrolidone. Other preferred binders are, for example, liquid to pasty nonionic surfactants which are liquid at the processing temperature.
Die Spreng- und Tablettierhilfsmittel werden vorzugsweise in trockener Form oder in einer in Niotensid gelösten bzw. suspendierten Form einge¬ setzt. Eine wäßrige Einsatzform ist weniger bevorzugt, da Wasser während des Verfahrensprozesses nur in den Mengen zugegeben werden darf, daß das maximale theoretische Wasserbindevermögen der Tabletteninhaltsstoffe nicht überschritten wird. In einer besonders bevorzugten Ausführungsform der Erfindung wird deshalb kein Inhaltsstoff in Form einer wäßrigen Lösung oder Suspension eingesetzt und die Verpressung also ohne Zugabe von Wasser durchgeführt.The disintegrants and tableting aids are preferably used in dry form or in a form dissolved or suspended in nonionic surfactant. An aqueous form of use is less preferred because water may only be added during the process in such quantities that the maximum theoretical water-binding capacity of the tablet ingredients is not exceeded. In a particularly preferred embodiment of the invention, therefore, no ingredient is in the form of an aqueous solution or suspension used and the pressing is carried out without the addition of water.
In einer bevorzugten Ausführungsform der Erfindung enthalten die Tabletten dabei insbesondere weitere übliche Buildersubstanzen. Zu diesen zählen anorganische Buildersubstanzen wie Zeolith und/oder Phosphate oder auch organische Buildersubstanzen wie Polycarboxylate und/oder polymere Poly- carboxylate.In a preferred embodiment of the invention, the tablets contain in particular further customary builder substances. These include inorganic builder substances such as zeolite and / or phosphates or organic builder substances such as polycarboxylates and / or polymeric polycarboxylates.
Dabei sind Tabletten bevorzugt, die 0,5 bis 98 Gew.-% wasserhaltigen Zeo¬ lith und/oder Phosphate enthalten, wobei der Gehalt an Phosphaten vorzugs¬ weise auf maximal 50 Gew.-% und insbesondere auf maximal 30 Gew.-% be¬ schränkt ist. In einer Wasserenthärtungstablette, die eine bevorzugte Aus¬ führungsform der Erfindung darstellt, sind jedoch 0 bis 80 Gew.-%, vor¬ zugsweise 5 bis 80 Gew.-% und insbesondere 10 bis 60 Gew.-% an wasserhal¬ tigem Zeolith und/oder Phosphat vorhanden. Bleichtabletten hingegen sind vorzugsweise frei von Zeolith, um negative Wechselwirkungen auszuschlie¬ ßen, können jedoch gegebenenfalls Phosphate enthalten.Tablets are preferred which contain 0.5 to 98% by weight of water-containing zeolite and / or phosphates, the phosphate content preferably being at most 50% by weight and in particular at most 30% by weight ¬ is limited. However, in a water softening tablet, which is a preferred embodiment of the invention, 0 to 80% by weight, preferably 5 to 80% by weight and in particular 10 to 60% by weight of water-containing zeolite and / or phosphate present. Bleaching tablets, on the other hand, are preferably free of zeolite in order to exclude negative interactions, but may optionally contain phosphates.
Der eingesetzte, feinkristalline, synthetische und gebundenes Wasser ent¬ haltene Zeolith ist dabei vorzugsweise Zeolith NaA in Waschmittelqualität. Geeignet sind jedoch auch Zeolith NaX, Zeolith P sowie Mischungen aus A, X oder P. Der Zeolith kann entweder als sprühgetrocknetes Pulver oder als granuläres Compound, das beispielsweise bis.zu etwa 50 Gew.-% andere Be¬ standteile wie nichtionische Tenside, Celluloseether und/oder polymere Polycarboxylate enthält, zum Einsatz kommen. Geeignete pulverförmige Zeolithe weisen eine mittlere Teilchengröße von weniger als 10 μ (Volu¬ menverteilung; Meßmethode: Coulter-Counter) auf und enthalten vorzugsweise 18 bis 22 Gew.-%, insbesondere 20 bis 22 Gew.-% an gebundenem Wasser.The fine crystalline, synthetic and bound water containing zeolite used is preferably zeolite NaA in detergent quality. However, zeolite NaX, zeolite P and mixtures of A, X or P are also suitable. The zeolite can be used either as a spray-dried powder or as a granular compound which, for example, contains up to about 50% by weight of other constituents such as nonionic surfactants and cellulose ethers and / or contains polymeric polycarboxylates. Suitable powdered zeolites have an average particle size of less than 10 μ (volume distribution; measurement method: Coulter counter) and preferably contain 18 to 22% by weight, in particular 20 to 22% by weight, of bound water.
In einer weiteren bevorzugten Ausführungsform der Erfindung enthalten die Tabletten 0,5 bis 50 Gew.-% organische Buildersubstanzen wie Polycarboxy¬ late und/oder polymere Polycarboxylate, aber auch deren Säuren. Wasserent¬ härtungstabletten enthalten vorzugsweise 0 bis 50 Gew.-%, insbesondere 0,5 bis 30 Gew.-% und vorteilhafterweise 2 bis 20 Gew.-% an Polycarboxylaten sowie zusätzlich vorzugsweise 0 bis 15 Gew.-%, insbesondere 0,5 bis 12 Gew.-% und vorteilhafterweise 1 bis 10 Gew.-% polymere Polycarboxylate. Zu den Polycarbonsäuren bzw. den Polycarboxylaten gehören insbesondere die in Form ihrer Natriumsalze eingesetzten Polycarbonsäuren wie Citronensäure, Adipinsäure, Bernsteinsäure, Glutarsäure, Weinsäure, Zuckersäuren und Mi¬ schungen aus diesen. Geeignete polymere Polycarboxylate sind beispiels¬ weise die Natriumsalze der Polyacrylsäure oder der Polymethacrylsäure, beispielsweise solche mit einer relativen Molekülmasse von 800 bis 150000 (auf Säure bezogen). Geeignete copolymere Polycarboxylate sind insbeson¬ dere solche der Acrylsäure mit Methacrylsäure und der Acrylsäure oder Methacrylsäure mit Maleinsäure. Als besonders geeignet haben sich Copoly¬ mere der Acrylsäure mit Maleinsäure erwiesen, die 50 bis 90 Gew.-% Acryl¬ säure und 50 bis 10 Gew.-% Maleinsäure enthalten. Ihre relative Molekül¬ masse, bezogen auf freie Säuren, beträgt im allgemeinen 5000 bis 200000, vorzugsweise 10000 bis 120000 und insbesondere 50000 bis 100000. Insbeson¬ dere bevorzugt sind auch terpolymere Polycarboxylate, beispielsweise sol¬ che, die als Monomere Salze der Acrylsäure und der Maleinsäure sowie Vi- nylalkohol bzw. Vinylalkohol-Derivate (DE-A-4300772) oder die als Mono¬ mere Salze der Acrylsäure und der 2-Alkylallylsulfonsäure sowie Zucker- Derivate (DE-C-4221 381) enthalten.In a further preferred embodiment of the invention, the tablets contain 0.5 to 50% by weight of organic builder substances such as polycarboxylates and / or polymeric polycarboxylates, but also their acids. Water softening tablets preferably contain 0 to 50% by weight, in particular 0.5 to 30% by weight and advantageously 2 to 20% by weight of polycarboxylates and additionally preferably 0 to 15% by weight, in particular 0.5 to 12th % By weight and advantageously 1 to 10% by weight of polymeric polycarboxylates. The polycarboxylic acids or the polycarboxylates include, in particular, the polycarboxylic acids used in the form of their sodium salts, such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids and mixtures thereof. Suitable polymeric polycarboxylates are, for example, the sodium salts of polyacrylic acid or polymethacrylic acid, for example those with a relative molecular weight of 800 to 150,000 (based on acid). Suitable copolymeric polycarboxylates are, in particular, those of acrylic acid with methacrylic acid and of acrylic acid or methacrylic acid with maleic acid. Copolymers of acrylic acid with maleic acid which contain 50 to 90% by weight of acrylic acid and 50 to 10% by weight of maleic acid have proven to be particularly suitable. Their relative molecular weight, based on free acids, is generally from 5,000 to 200,000, preferably from 10,000 to 120,000 and in particular from 50,000 to 100,000. Terpolymeric polycarboxylates are also particularly preferred, for example those which are salts of acrylic acid and of monomers Maleic acid and vinyl alcohol or vinyl alcohol derivatives (DE-A-4300772) or the monomers as salts of acrylic acid and 2-alkylallylsulfonic acid and sugar derivatives (DE-C-4221 381).
Die (co-)polymeren Polycarboxylate werden vorzugsweise entweder als Pulver oder als granuläres Compound eingesetzt. Als granuläre Compounds eignen sich beispielsweise solche, die aus der internationalen Patentanmeldung W0-A-92/13937 bekannt sind.The (co) polymeric polycarboxylates are preferably used either as a powder or as a granular compound. Suitable granular compounds are, for example, those known from international patent application WO-A-92/13937.
Weitere geeignete Buildersysteme sind Oxidationsprodukte von carboxylgrup- penhaltigen Polyglucosanen und/oder deren wasserlöslichen Salzen, wie sie beispielsweise in der internationalen Patentanmeldung W0-A-93/08251 be¬ schrieben werden oder deren Herstellung beispielsweise in der internatio¬ nalen Patentanmeldung W0-A-93/16110 beschrieben wird.Other suitable builder systems are oxidation products of carboxyl group-containing polyglucosans and / or their water-soluble salts, as described, for example, in international patent application WO-A-93/08251 or their production, for example, in international patent application WO-A-93 / 16110.
Weitere geeignete Buildersubstanzen sind Polyacetale, welche durch Umset¬ zung von Dialdehyden mit Polyolcarbonsäuren, welche 5 bis 7 C-Atome und mindestens 3 Hydroxylgruppen aufweisen, beispielsweise wie in der euro¬ päischen Patentanmeldung EP-A-0 280 223 beschrieben erhalten werden kön¬ nen. Bevorzugte Polyacetale werden aus Dialdehyden wie Glyoxal, Glutar- aldehyd, Terephthalaldehyd sowie deren Gemischen und aus Polyolcarbonsäu- ren wie Gluconsäure und/oder Glucoheptonsäure erhalten.Other suitable builder substances are polyacetals, which can be obtained by reacting dialdehydes with polyolcarboxylic acids which have 5 to 7 carbon atoms and at least 3 hydroxyl groups, for example as described in European patent application EP-A-0 280 223 . Preferred polyacetals are derived from dialdehydes such as glyoxal, glutar aldehyde, terephthalaldehyde and mixtures thereof and from polyol carboxylic acids such as gluconic acid and / or glucoheptonic acid.
In einer weiteren bevorzugten Ausführungsform der Erfindung weisen die Tabletten bis zu 40 Gew.-% Aniontenside und/oder Seifen auf. Als anioni¬ sche Tenside werden beispielsweise solche vom Typ der Sulfonate und Sulfa¬ te eingesetzt.In a further preferred embodiment of the invention, the tablets have up to 40% by weight of anionic surfactants and / or soaps. The anionic surfactants used are, for example, those of the sulfonate and sulfate types.
Als Tenside vom Sulfonat-Typ kommen vorzugsweise Cg-Ci3-Alkylbenzolsul- fonate, Olefinsulfonate, d.h. Gemische aus Alken- und Hydroxyalkansulfona- ten sowie Disulfonaten, wie man sie beispielsweise aus Ci2-Ci8-Monoolefi- nen mit end- oder innenständiger Doppelbindung durch Sulfonieren mit gas¬ förmigem Schwefeltrioxid und anschließende alkalische oder saure Hydrolyse der Sulfonierungsprodukte erhält, in Betracht.Preferred surfactants of the sulfonate type are Cg-Ci3-alkylbenzenesulfonates, olefin sulfonates, i.e. Mixtures of alkene and hydroxyalkanesulfonates and disulfonates, such as those obtained, for example, from Ci2-Ci8 monoolefins with a terminal or internal double bond by sulfonation with gaseous sulfur trioxide and subsequent alkaline or acidic hydrolysis of the sulfonation products.
Geeignet sind auch Alkansulfonate, die aus Ci -Ci8-Alkanen beispielsweise durch Sulfochlorierung oder Sulfoxidation mit anschließender Hydrolyse bzw. Neutralisation gewonnen werden.Also suitable are alkanesulfonates obtained from C 1 -C 8 -alkanes, for example by sulfochlorination or sulfoxidation with subsequent hydrolysis or neutralization.
Geeignet sind auch die Ester von α-Sulfofettsäuren (Estersulfonate), z.B. die α-sulfonierten Methylester der hydrierten Kokos-, Palmkern- oder Taig¬ fettsäuren.Also suitable are the esters of α-sulfo fatty acids (ester sulfonates), e.g. the α-sulfonated methyl esters of hydrogenated coconut, palm kernel or Taig¬ fatty acids.
Weitere geeignete Aniontenside sind sulfierte Fettsäureglycerinester. Un¬ ter Fettsäureglycerinestern sind die Mono-, Di- und Triester sowie deren Gemische zu verstehen, wie sie bei der Herstellung durch Veresterung durch ein Monoglycerin mit 1 bis 3 Mol Fettsäure oder bei .der Umesterung von Triglyceriden mit 0,3 bis 2 Mol Glycerin erhalten werden. Bevorzugte sul¬ fierte Fettsäureglycerinester sind dabei die Sulfierprodukte von gesättig¬ ten Fettsäuren mit 6 bis 22 Kohlenstoffatomen, beispielsweise der Capron- säure, Caprylsäure, Caprinsäure, Myristinsäure, Laurinsäure, Palmitinsäu- re, Stearinsäure oder Behensäure. Geht man dabei von Fetten und Ölen, also natürlichen Gemischen unterschiedlicher Fettsäureglycerinester aus, so ist es erforderlich, die Einsatzprodukte vor der Sulfierung in an sich bekann¬ ter Weise mit Wasserstoff weitgehend abzusättigen, d.h. auf Iodzahlen kleiner 5, vorteilhafterweise kleiner 2 zu härten. Typische Beispiele ge- eigneter Einsatzstoffe sind Palmöl, Palmkernöl, Palmstearin, Olivenöl, Rüböl, Korianderöl, Sonnenblumenöl, Baumwollsaatöl, Erdnußöl, Leinöl, Lardöl oder Schweineschmalz. Aufgrund ihres hohen natürlichen Anteils an gesättigten Fettsäuren hat es sich jedoch als besonders vorteilhaft erwie¬ sen, von Kokosöl, Palmkernöl oder Rindertalg auszugehen. Die Sulfierung der gesättigten Fettsäuren mit 6 bis 22 Kohlenstoffatomen oder der Mi¬ schungen aus Fettsäureglycerinestern mit Iodzahlen kleiner 5, die Fett¬ säuren mit 6 bis 22 Kohlenstoffatomen enthalten, erfolgt vorzugsweise durch Umsetzung mit gasförmigem Schwefeltrioxid und anschließender Neu¬ tralisierung mit wäßrigen Basen, wie sie in der internationalen Patentan¬ meldung W0-A-91/09009 angegeben ist.Other suitable anionic surfactants are sulfonated fatty acid glycerol esters. Fatty acid glycerol esters are to be understood as the mono-, di- and triesters as well as their mixtures, as they are in the production by esterification by a monoglycerol with 1 to 3 moles of fatty acid or in the transesterification of triglycerides with 0.3 to 2 moles of glycerol be preserved. Preferred sulfated fatty acid glycerol esters are the sulfonation products of saturated fatty acids having 6 to 22 carbon atoms, for example capric acid, caprylic acid, capric acid, myristic acid, lauric acid, palmitic acid, stearic acid or behenic acid. If one starts from fats and oils, that is to say natural mixtures of different fatty acid glycerol esters, it is necessary to largely saturate the starting products with hydrogen in a manner known per se, ie to harden them to iodine numbers less than 5, advantageously less than 2. Typical examples Suitable feedstocks are palm oil, palm kernel oil, palm stearin, olive oil, turnip oil, coriander oil, sunflower oil, cottonseed oil, peanut oil, linseed oil, lard oil or lard. Due to their high natural content of saturated fatty acids, it has proven to be particularly advantageous to start from coconut oil, palm kernel oil or beef tallow. The sulfonation of the saturated fatty acids with 6 to 22 carbon atoms or the mixtures of fatty acid glycerol esters with iodine numbers less than 5, which contain fatty acids with 6 to 22 carbon atoms, is preferably carried out by reaction with gaseous sulfur trioxide and subsequent neutralization with aqueous bases, such as it is specified in the international patent application WO-A-91/09009.
Als Alk(en)ylsulfate werden die Schwefelsäurehalbester der C^-Cis-Fettal- kohole beispielsweise aus Kokosfettalkohol, Taigfettalkohol, Lauryl-, My- ristyl-, Cetyl- oder Stearylalkohol oder der Cιo-C2θ_0xoalkohole und die¬ jenigen Halbester sekundärer Alkohole dieser Kettenlänge bevorzugt. Wei¬ terhin bevorzugt sind Alk(en)ylsulfate der genannten Kettenlänge, welche einen synthetischen, auf petrochemischer Basis hergestellten geradkettigen Alkylrest enthalten, die ein analoges Abbauverhalten besitzen wie die ad¬ äquaten Verbindungen auf der Basis von fettchemischen Rohstoffen. Aus waschtechnischem Interesse sind Cχ6-Ci8-Alk(en)ylsulfate insbesondere be¬ vorzugt. Dabei kann es auch von besonderem Vorteil und insbesondere für maschinelle Waschmittel von Vorteil sein, Ci6-Ci8-Alk(en)ylsulfate in Kom¬ bination mit niedriger schmelzenden Aniontensiden und insbesondere mit solchen Aniontensiden, die einen niedrigeren Krafft-Punkt aufweisen und bei relativ niedrigen Waschtemperaturen von beispielsweise Raumtemperatur bis 40 °C eine geringe Kristallisationsneigung zeigen, einzusetzen. In einer bevorzugten Ausführungsform der Erfindung enthalten die Mittel daher Mischungen aus kurzkettigen und langkettigen Fettalkylsulfaten, vorzugs¬ weise Mischungen aus Ci2-Ci4-Fettalkylsulfaten oder Ci2-Ci8-Fettalkylsul- faten mit Ci6-Ci8~Fettalkylsulfaten und insbesondere Ci2-Ci6-Fettalkyl- sulfaten mit Ci6-Ci8-Fettalkylsulfaten. In einer weiteren bevorzugten Aus¬ führungsform der Erfindung werden jedoch nicht nur gesättigte Alkylsul- fate, sondern auch ungesättigte Alkenylsulfate mit einer Alkenylketten- länge von vorzugsweise Cj6 bis C22 eingesetzt. Dabei sind insbesondere Mischungen aus gesättigten, überwiegend aus Ci6 bestehenden sulfierten Fettalkoholen und ungesättigten, überwiegend aus CJS bestehenden sulfier- ten Fettalkoholen bevorzugt, beispielsweise solche, die sich von festen oder flüssigen Fettalkoholmischungen des Typs HD-Ocenol (R) (Handelspro¬ dukt des Anmelders) ableiten. Dabei sind Gewichtsverhältnisse von Alkyl- sulfaten zu Alkenylsulfaten von 10:1 bis 1:2 und insbesondere von etwa 5:1 bis 1:1 bevorzugt.Alk (en) yl sulfates are the Schwefelsäurehalbester the C ^ -cis-fatty alcohols are, for example, from coconut fatty alcohol, tallow fatty alcohol, lauryl, myristyl ristyl-, cetyl or stearyl alcohol, or Cιo-C2θ _ 0xoalkohole and have those Halbester secondary alcohols this chain length preferred. Also preferred are alk (en) yl sulfates of the chain length mentioned which contain a synthetic, petrochemical-based straight-chain alkyl radical which have a degradation behavior analogous to that of the corresponding compounds based on oleochemical raw materials. Cχ6-Ci8-alk (en) yl sulfates are particularly preferred for washing technology reasons. It can also be particularly advantageous, and particularly advantageous for machine washing agents, to use Ci6-Ci8-alk (en) yl sulfates in combination with lower melting anionic surfactants and in particular with those anionic surfactants which have a lower Krafft point and relatively low ones Washing temperatures of, for example, room temperature to 40 ° C. show a low tendency to crystallize. In a preferred embodiment of the invention, the compositions therefore contain mixtures of short-chain and long-chain fatty alkyl sulfates, preferably mixtures of Ci2-Ci4-fatty alkyl sulfates or Ci2-Ci8-fatty alkyl sulfates with Ci6-Ci8 ~ fatty alkyl sulfates and in particular Ci2-Ci6-fatty alkyl sulfates with Ci6-Ci8 fatty alkyl sulfates. In a further preferred embodiment of the invention, however, not only saturated alkyl sulfates but also unsaturated alkenyl sulfates with an alkenyl chain length of preferably C 6 to C 22 are used. In particular, mixtures of saturated, predominantly Ci6 sulfated Fatty alcohols and unsaturated, sulfated fatty alcohols consisting predominantly of CJS are preferred, for example those which are derived from solid or liquid fatty alcohol mixtures of the HD-Ocenol ( R ) type (commercial product of the applicant). Weight ratios of alkyl sulfates to alkenyl sulfates of 10: 1 to 1: 2 and in particular of about 5: 1 to 1: 1 are preferred.
Auch die Schwefelsäuremonoester der mit 1 bis 6 Mol Ethylenoxid ethoxy¬ lierten geradkettigen oder verzweigten C7~C2i-Alkohole, wie 2-Methyl-ver- zweigte Cg-Cn-Alkohole mit im Durchschnitt 3,5 Mol Ethylenoxid (EO) oder Cj2-Ci8-Fettalkohole mit 2 bis 4 EO, sind geeignet. Sie werden in Wasch¬ mitteln aufgrund ihres hohen Schaumverhaltens nur in relativ geringen Men¬ gen, beispielsweise in Mengen von 1 bis 5 Gew.-%, eingesetzt.The sulfuric acid monoesters of the straight-chain or branched C7 ~ C2i alcohols ethoxylated with 1 to 6 moles of ethylene oxide, such as 2-methyl-branched Cg-Cn alcohols with an average of 3.5 moles of ethylene oxide (EO) or C j 2 -Ci8 fatty alcohols with 2 to 4 EO are suitable. Because of their high foaming behavior, they are used in detergents only in relatively small amounts, for example in amounts of 1 to 5% by weight.
Bevorzugte Aniontenside sind auch die Salze der Alkylsulfobernsteinsäure, die auch als Sulfosuccinate oder als Sulfobernsteinsäureester bezeichnet werden und die Monoester und/oder Diester der Sulfobernsteinsäure mit Al¬ koholen, vorzugsweise Fettalkoholen und insbesondere ethoxylierten Fett¬ alkoholen darstellen. Bevorzugte Sulfosuccinate enthalten Cs- bis Ci8- Fettalkoholreste oder Mischungen aus diesen. Insbesondere bevorzugte Sul¬ fosuccinate enthalten einen Fettalkoholrest, der sich von ethoxylierten Fettalkoholen ableitet, die für sich betrachtet nichtionische Tenside dar¬ stellen (Beschreibung siehe unten). Dabei sind wiederum Sulfosuccinate, deren Fettalkohol-Reste sich von ethoxylierten Fettalkoholen mit eingeeng¬ ter Homologenverteilung ableiten, besonders bevorzugt. Ebenso ist es auch möglich, Alk(en)ylbernsteinsäure mit vorzugsweise 8 bis 18 Kohlenstoffato¬ men in der Alk(en)ylkette oder deren Salze einzusetzen.Preferred anionic surfactants are also the salts of alkylsulfosuccinic acid, which are also referred to as sulfosuccinates or as sulfosuccinic acid esters and which are monoesters and / or diesters of sulfosuccinic acid with alcohols, preferably fatty alcohols and in particular ethoxylated fatty alcohols. Preferred sulfosuccinates contain Cs to Ci8 fatty alcohol residues or mixtures thereof. Particularly preferred sulfosuccinates contain a fatty alcohol residue which is derived from ethoxylated fatty alcohols which, viewed in isolation, are nonionic surfactants (for a description, see below). Again, sulfosuccinates, the fatty alcohol residues of which are derived from ethoxylated fatty alcohols with a narrow homolog distribution, are particularly preferred. It is also possible to use alk (en) ylsuccinic acid with preferably 8 to 18 carbon atoms in the alk (en) yl chain or salts thereof.
Bevorzugte Aniontensid-Mischungen enthalten Kombinationen aus Alk(en)yl- sulfaten, insbesondere Mischungen aus gesättigten und ungesättigten Fett- alk(en)ylsulfaten, und Alkylbenzolsulfonaten, sulfierten Fettsäureglyce- rinestern und/oder -Sulfofettsäureestern. Insbesondere sind hierbei Mi¬ schungen bevorzugt, die als anionische Tenside Alk(en)ylsulfate und Alkyl- benzolsulfonate, Alk(en)ylsulfate und α-Sulfofettsäuremethylester und/oder sulfierte Fettsäureglycerinester enthalten. Als weitere anionische Tenside kommen insbesondere Seifen, vorzugsweise in Mengen von 0,1 bis 5 Gew.-%, in Betracht. Geeignet sind beispielsweise gesättigte Fettsäureseifen, wie die Salze der Laurinsäure, Myristinsäure, Palmitinsäure oder Stearinsäure, sowie insbesondere aus natürlichen Fett¬ säuren, z.B. Kokos-, Palmkern- oder Taigfettsäuren, abgeleitete Seifenge¬ mische. Insbesondere sind solche Seifengemische bevorzugt, die zu 50 bis 100 Gew.-% aus gesättigten Ci2-C24~Fettsäureseifen und zu 0 bis 50 Gew.-% aus Ölsäureseife zusammengesetzt sind.Preferred anionic surfactant mixtures contain combinations of alk (en) yl sulfates, in particular mixtures of saturated and unsaturated fatty alk (en) yl sulfates, and alkylbenzenesulfonates, sulfated fatty acid glycerol esters and / or sulfofatty acid esters. In particular, mixtures are preferred which contain alk (en) yl sulfates and alkylbenzenesulfonates, alk (en) yl sulfates and methyl α-sulfofatty acid and / or sulfated fatty acid glycerol esters as anionic surfactants. Other suitable anionic surfactants are, in particular, soaps, preferably in amounts of 0.1 to 5% by weight. For example, saturated fatty acid soaps are suitable, such as the salts of lauric acid, myristic acid, palmitic acid or stearic acid, and in particular soap mixtures derived from natural fatty acids, for example coconut, palm kernel or tallow fatty acids. In particular, those soap mixtures are preferred which are composed of 50 to 100% by weight saturated C12-C24 fatty acid soaps and 0 to 50% by weight oleic acid soap.
Die anionischen Tenside und Seifen können in Form ihrer Natrium-, Kalium¬ oder Ammoniumsalze sowie als lösliche Salze organischer Basen, wie Mono-, Di- oder Triethanolamin, vorliegen. Vorzugsweise liegen die anionischen Tenside in Form ihrer Natrium- oder Kaliumsalze, insbesondere in Form der Natriumsalze vor.The anionic surfactants and soaps can be present in the form of their sodium, potassium or ammonium salts and as soluble salts of organic bases, such as mono-, di- or triethanolamine. The anionic surfactants are preferably in the form of their sodium or potassium salts, in particular in the form of the sodium salts.
Als nichtionische Tenside werden vorzugsweise alkoxylierte, vorteilhaf¬ terweise ethoxylierte, insbesondere primäre Alkohole mit vorzugsweise 8 bis 18 C-Atomen und durchschnittlich 1 bis 12 Mol Ethylenoxid (E0) pro Mol Alkohol eingesetzt, in denen der Alkoholrest linear oder bevorzugt in 2- Stellung methylverzweigt sein kann bzw. lineare und methylverzweigte Reste im Gemisch enthalten kann, so wie sie üblicherweise in Oxoalkoholresten vorliegen. Insbesondere sind jedoch Alkoholethoxylate mit linearen Resten aus Alkoholen nativen Ursprungs mit 12 bis 18 C-Atomen, z.B. aus Kokos-, Palm-, Taigfett- oder Oleylalkohol, und durchschnittlich 2 bis 8 E0 pro Mol Alkohol bevorzugt. Zu den bevorzugten ethoxylierten Alkoholen gehören beispielsweise Ci2-Ci4-Alkohole mit 3 E0 oder 4 E0, Cg-Cn-Alkohol mit 7 E0, Ci3-Ci5-Alkohole mit 3 E0, 5 E0, 7 E0 oder 8 E0, Ci2-Ci8-Alkohole mit 3 E0, 5 E0 oder 7 E0 und Mischungen aus diesen, wie Mischungen aus C12- Ci4-Alkohol mit 3 E0 und Ci2-Ci8-Alkohol mit 5 E0. Die angegebenen Ethoxy- lierungsgrade stellen statistische Mittelwerte dar, die für ein spezielles Produkt eine ganze oder eine gebrochene Zahl sein können. Bevorzugte Alko¬ holethoxylate weisen eine eingeengte Homologenverteilung auf (narrow ränge ethoxylates, NRE). Zusätzlich zu diesen nichtionischen Tensiden können auch Fettalkohole mit mehr als 12 E0, beispielsweise solche bis zu etwa 80 E0, eingesetzt werden. Beispiele hierfür sind Taigfettalkohol mit 14 E0, 25 E0, 30 E0 oder 40 E0. Außerdem können als weitere nichtionische Tenside auch Alkylglykoside der allgemeinen Formel R0(G)x eingesetzt werden, in der R einen primären ge- radkettigen oder methylverzweigten, insbesondere in 2-Stellung methylver¬ zweigten aliphatischen Rest mit 8 bis 22, vorzugsweise 12 bis 18 C-Atomen bedeutet und G das Symbol ist, das für eine Glykoseeinheit mit 5 oder 6 C-Atomen, vorzugsweise für Glucose, steht. Der Oligomerisierungsgrad x, der die Verteilung von Monoglykosiden und Oligoglykosiden angibt, ist eine beliebige Zahl zwischen 1 und 10; vorzugsweise liegt x bei 1,2 bis 1,4.The nonionic surfactants used are preferably alkoxylated, advantageously ethoxylated, in particular primary alcohols having preferably 8 to 18 carbon atoms and an average of 1 to 12 moles of ethylene oxide (E0) per mole of alcohol in which the alcohol radical has a methyl or linear branching, preferably in the 2-position may be or may contain linear and methyl-branched radicals in the mixture, as are usually present in oxo alcohol radicals. However, alcohol ethoxylates with linear residues of alcohols of native origin with 12 to 18 carbon atoms, for example from coconut, palm, tallow fat or oleyl alcohol, and an average of 2 to 8 E0 per mole of alcohol are particularly preferred. The preferred ethoxylated alcohols include, for example, Ci2-Ci4 alcohols with 3 E0 or 4 E0, Cg-Cn alcohol with 7 E0, Ci3-Ci5 alcohols with 3 E0, 5 E0, 7 E0 or 8 E0, Ci2-Ci8- Alcohols with 3 E0, 5 E0 or 7 E0 and mixtures of these, such as mixtures of C12-Ci4 alcohol with 3 E0 and Ci2-Ci8 alcohol with 5 E0. The degrees of ethoxylation given represent statistical averages, which can be an integer or a fraction for a specific product. Preferred alcohol ethoxylates have a narrow homolog distribution (narrow range ethoxylates, NRE). In addition to these nonionic surfactants, fatty alcohols with more than 12 E0, for example those up to about 80 E0, can also be used. Examples of this are tallow fatty alcohol with 14 E0, 25 E0, 30 E0 or 40 E0. In addition, alkyl glycosides of the general formula R0 (G) x , in which R is a primary straight-chain or methyl-branched, in particular methyl-branched aliphatic radical having 8 to 22, preferably 12 to 18, C., can also be used as further nonionic surfactants -Atoms means and G is the symbol which stands for a glycose unit with 5 or 6 carbon atoms, preferably for glucose. The degree of oligomerization x, which indicates the distribution of monoglycosides and oligoglycosides, is any number between 1 and 10; x is preferably 1.2 to 1.4.
Auch nichtionische Tenside vom Typ der Aminoxide, beispielsweise N-Kokos- alkyl-N.N-dimethyla inoxid und N-Talgalkyl-N.N-dihydroxyethylaminoxid, und der Fettsäurealkanolamide können geeignet sein. Die Menge dieser nicht¬ ionischen Tenside beträgt vorzugsweise nicht mehr als die der ethoxylier¬ ten Fettalkohole, insbesondere nicht mehr als die Hälfte davon.Nonionic surfactants of the amine oxide type, for example N-cocoalkyl-N.N-dimethyla inoxide and N-tallow alkyl-N.N-dihydroxyethylamine oxide, and the fatty acid alkanolamides may also be suitable. The amount of these non-ionic surfactants is preferably not more than that of the ethoxylated fatty alcohols, in particular not more than half of them.
Weitere geeignete Tenside sind Polyhydroxyfettsäureamide der Formel (I),Other suitable surfactants are polyhydroxy fatty acid amides of the formula (I),
R3R3
R2-C0-N-[Z] (I)R 2 -C0-N- [Z] (I)
in der R2C0 für einen aliphatischen Acylrest mit 6 bis 22 Kohlenstoffato- men, R^ für Wasserstoff, einen Alkyl- oder Hydroxyalkylrest mit 1 bis 4 Kohlenstoffatomen und [Z] für einen linearen oder verzweigten Polyhydro- xyalkylrest mit 3 bis 10 Kohlenstoffatomen und 3 bis 10 Hydroxylgruppen steht.in which R 2 is C0 for an aliphatic acyl radical with 6 to 22 carbon atoms, R ^ for hydrogen, an alkyl or hydroxyalkyl radical with 1 to 4 carbon atoms and [Z] for a linear or branched polyhydroxyalkyl radical with 3 to 10 carbon atoms and 3 to 10 hydroxyl groups.
Die Tabletten enthalten die nichtionischen Tenside in einer bevorzugten Ausführungsform in Mengen bis zu 20 Gew.-%.In a preferred embodiment, the tablets contain the nonionic surfactants in amounts of up to 20% by weight.
Weitere bevorzugte Inhaltsstoffe sind in Wasser alkalisch reagierende an¬ organische Salze, die vorzugsweise bis zu 15 Gew.-% in den Tabletten ent¬ halten sind. Zu diesen anorganischen alkalisch reagierenden Salzen gehören insbesondere Bicarbonate, Carbonate oder Mischungen aus diesen; vorzugs¬ weise werden Alkalicarbonat und vor allem Natriumkarbonat eingesetzt. Weiterhin können die Tabletten in Wasser neutral reagierenden anorgani¬ schen Salzen, vorzugsweise Sulfate und Chloride, insbesondere in Form ihrer Natrium- und/oder Calciu salze enthalten. Ihr Gehalt in den Tablet¬ ten beträgt vorzugsweise bis zu etwa 20 Gew.-%.Other preferred ingredients are alkaline organic salts in water, which are preferably up to 15% by weight in the tablets. These inorganic alkaline salts include in particular bicarbonates, carbonates or mixtures thereof; Alkali carbonate and especially sodium carbonate are preferably used. The tablets can furthermore contain inorganic salts which react neutral in water, preferably sulfates and chlorides, in particular in the form of their sodium and / or calcium salts. Their content in the tablets is preferably up to about 20% by weight.
Eine weitere Ausführungsform der Erfindung betrifft Wasserenthärtungsta¬ bletten, die 0 bis 30 Gew.-%, vorzugsweise aber 0,5 bis 20 Gew.-% und ins¬ besondere zu 2 bis 15 Gew.-% aus den genannten Aniontensiden, Niotensiden, alkalisch oder neutral reagierenden anorganischen Salzen oder Mischungen aus diesen bestehen.A further embodiment of the invention relates to water softening tablets which are 0 to 30% by weight, but preferably 0.5 to 20% by weight and in particular 2 to 15% by weight, of the anionic surfactants, nonionic surfactants mentioned, alkaline or neutral reacting inorganic salts or mixtures of these.
Als weitere wichtige Inhaltsstoffe von Tabletten können insbesondere Per- oxy-Bleich ittel und Bleichaktivatoren genannt werden. Unter den als Bleichmittel dienenden, in Wasser H2O2 liefernden Verbindungen haben das Natriumperborattetrahydrat und das Natriumperboratmonohydrat besondere Bedeutung. Weitere brauchbare Bleichmittel sind beispielsweise Natriu - percarbonat, Peroxypyrophosphate, Citratperhydrate sowie H2O2 liefernde persaure Salze oder Persäuren, wie Perbenzoate, Peroxophthalate, Diperaze- lainsäure oder Diperdodecandisäure. Besonders bevorzugt sind Peroxy- Bleichmittel, welche pro Mol der Komponente 10 bis 20 % Aktivsauerstoff liefern. Der Gehalt der Tabletten an Bleichmitteln beträgt vorzugsweise 15 bis 60 Gew.-% und insbesondere 10 bis 50 Gew.-%, wobei vorteilhafterweise Perboratmonohydrat eingesetzt wird.Peroxy bleaching agents and bleach activators can be mentioned as further important ingredients of tablets. Of the compounds which provide H2O2 in water and serve as bleaching agents, sodium perborate tetrahydrate and sodium perborate monohydrate are of particular importance. Further usable bleaching agents are, for example, sodium percarbonate, peroxypyrophosphates, citrate perhydrates and H2O2-providing peracidic salts or peracids, such as perbenzoates, peroxophthalates, diperazelaic acid or diperdodecanedioic acid. Peroxy bleaching agents which deliver 10 to 20% active oxygen per mole of component are particularly preferred. The bleaching agent content of the tablets is preferably 15 to 60% by weight and in particular 10 to 50% by weight, advantageously using perborate monohydrate.
Um beim Waschen bei Temperaturen von 60 °C und darunter eine verbesserte Bleichwirkung zu erreichen, können Bleichaktivatoren in die Präparate ein¬ gearbeitet werden. Beispiele hierfür sind mit H2O2 organische Persäuren bildende N-Acyl- bzw. O-Acyl-Verbindungen, vorzugsweise N,N'-tetraacylier- te Diamine, ferner Carbonsäureanhydride und Ester von Polyolen wie Gluco- sepentaacetat. Weitere bekannte Bleichaktivatoren sind acetylierte Mi¬ schungen aus Sorbitol und Mannitol, wie sie beispielsweise in der europä¬ ischen Patentanmeldung EP-A-0 525 239 beschrieben werden. Der Gehalt der bleichmittelhaltigen Mittel an Bleichaktivatoren liegt in dem üblichen Bereich, vorzugsweise zwischen 1 und 10 Gew.-% und insbesondere zwischen 3 und 8 Gew.-%. Besonders bevorzugte Bleichaktivatoren sind N,N,N' ,N'-Tetra- acetylethylendia in (TAED), l,5-Diacetyl-2,4-dioxo-hexahydro-l,3,5-triazin (DADHT) und acetylierte Sorbitol-Mannitol-Mischungen (SORMAN). Die Bleich¬ aktivatoren können insbesondere auch in granulärer Form als Compound bei der Verpressung eingesetzt werden.In order to achieve an improved bleaching effect when washing at temperatures of 60 ° C. and below, bleach activators can be incorporated into the preparations. Examples of this are N-acyl or O-acyl compounds which form organic peracids with H2O2, preferably N, N'-tetraacylated diamines, furthermore carboxylic acid anhydrides and esters of polyols such as glucose sepentaacetate. Other known bleach activators are acetylated mixtures of sorbitol and mannitol, as described, for example, in European patent application EP-A-0 525 239. The bleach activators contain bleach activators in the usual range, preferably between 1 and 10% by weight and in particular between 3 and 8% by weight. Particularly preferred bleach activators are N, N, N ', N'-tetraacetylethylene diamine in (TAED), 1,5-diacetyl-2,4-dioxo-hexahydro-1,3,5-triazine (DADHT) and acetylated sorbitol-mannitol mixtures (SORMAN). The bleach activators can in particular also be used in granular form as a compound in the pressing.
Bleichende Waschmitteltabletten enthalten Peroxy-Bleichmittel vorzugsweise in Mengen von 5 bis 30 Gew.-% und insbesondere von 10 bis 25 Gew.-%. Ta¬ bletten, die jedoch als bleichende Tablette, also als Bleichbooster zu¬ sätzlich zu anderen Waschmittelformulierungen, die gegebenenfalls in Ta¬ blettenform vorliegen können, eingesetzt werden, enthalten Peroxy-Bleich¬ mittel vorzugsweise in Mengen von 20 bis 50 Gew.-% und insbesondere in Mengen von 25 bis 45 Gew.-%. Dabei kann ein Gehalt an Percarbonat in Men¬ gen von 10 bis 40 Gew.-% besonders vorteilhaft sein, wenn insbesondere bei niedrigen Percarbonatgehalten unterhalb 20 Gew.-% noch weitere Peroxy- Bleichmittel eingesetzt werden. Eine bevorzugte bleichende Tablette zeich¬ net sich dadurch aus, daß sie 20 bis 80 Gew.-%, vorzugsweise 30 bis 60 Gew.- aus amorphen, teilkristallinen und/oder kristallinen schichtförmi¬ gen Natriums likaten der angegebenen Formel und 20 bis 50, vorzugsweise 25 bis 45 Gew.-% Peroxy-Bleichmittel, aber keinen Zeolith enthält.Bleaching detergent tablets preferably contain peroxy bleach in amounts of 5 to 30% by weight and in particular 10 to 25% by weight. Tablets which are used as bleaching tablets, ie as bleach boosters in addition to other detergent formulations, which may be in tablet form, preferably contain peroxy bleaches in amounts of 20 to 50% by weight and especially in amounts of 25 to 45% by weight. A content of percarbonate in amounts of 10 to 40% by weight can be particularly advantageous if additional peroxy bleaching agents are used in particular at low percarbonate contents below 20% by weight. A preferred bleaching tablet is characterized in that it contains 20 to 80% by weight, preferably 30 to 60% by weight, of amorphous, partially crystalline and / or crystalline layered sodium likates of the formula given and 20 to 50, preferably 25 to 45% by weight peroxy bleach, but does not contain zeolite.
Die Tabletten können auch noch weitere Inhaltsstoffe von Wasch- oder Rei¬ nigungsmitteln enthalten. Zu diesen zählen übliche Soil-Release- und Soil- Repellent-Verbindungen, aber auch Löslichkeitsverbesserer, Vergrauungs- inhibitoren, Schauminhibitoren, optische Aufheller, Enzyme, textilweich- machende Stoffe sowie Färb- und Duftstoffe. Ihr Gehalt in den erfindungs¬ gemäßen Tabletten geht vorzugsweise nicht über 10 Gew.-% hinaus.The tablets can also contain further ingredients of washing or cleaning agents. These include common soil release and soil repellent compounds, but also solubility improvers, graying inhibitors, foam inhibitors, optical brighteners, enzymes, fabric softening agents, and colorants and fragrances. Their content in the tablets according to the invention preferably does not exceed 10% by weight.
Die Mittel können also auch Komponenten enthalten, welche die Öl- und Fettauswaschbarkeit aus Textilien positiv beeinflussen. Dieser Effekt wird besonders deutlich, wenn ein Textil verschmutzt wird, das bereits vorher mehrfach mit einem erfindungsgemäßen Waschmittel, das diese öl- und fett¬ lösende Komponente enthält, gewaschen wird. Zu den bevorzugten öl- und fettlösenden Komponenten zählen beispielsweise nichtionische Cellulose- ether wie Methylhydroxypropylcellulose mit einem Anteil an Methoxyl-Grup¬ pen von 15 bis 30 Gew.-% und an Hydroxypropoxyl-Gruppen von 1 bis 15 Gew.-%, jeweils bezogen auf den nichtionischen Celluloseether, sowie die aus dem Stand der Technik bekannten Polymere der Phthalsäure und/oder der Therephthalsäure bzw. von deren Derivaten, insbesondere Polymere aus Ethylentherephthalaten und/oder Polyethylenglykol-Therephthalaten.The agents can therefore also contain components which have a positive influence on the oil and fat washability from textiles. This effect is particularly evident when a textile is contaminated which has already been washed several times beforehand with a detergent according to the invention which contains this oil- and fat-dissolving component. The preferred oil- and fat-dissolving components include, for example, nonionic cellulose ethers such as methyl hydroxypropyl cellulose with a proportion of methoxyl groups of 15 to 30% by weight and of hydroxypropoxyl groups of 1 to 15% by weight, based in each case the nonionic cellulose ether, and the polymers of phthalic acid and / or the known from the prior art Therephthalic acid or its derivatives, in particular polymers of ethylene terephthalates and / or polyethylene glycol terephthalates.
Die Mittel können außerdem Bestandteile enthalten, welche die Löslichkeit einzelner Bestandteile der Tabletten und somit auch die Auflösegeschwin- digkeit der Tablette selber positiv beeinflussen. Zu den bevorzugten zu¬ sätzlich eingesetzten Bestandteilen gehören außer den bereits beschriebe¬ nen Fettalkoholen mit 10 bis 80 Mol Ethylenoxid pro Mol Fettalkohol insbe¬ sondere Polyethylenglykole mit einer relativen Molekülmasse zwischen 200 und 4000.The agents can also contain constituents which have a positive influence on the solubility of individual constituents of the tablets and thus also on the dissolution speed of the tablet itself. In addition to the already described fatty alcohols with 10 to 80 moles of ethylene oxide per mole of fatty alcohol, the preferred additional components used include, in particular, polyethylene glycols with a relative molecular weight of between 200 and 4000.
Beim Einsatz in maschinellen Waschverfahren kann es von Vorteil sein, den Mitteln übliche Schauminhibitoren zuzusetzen. Als Schauminhibitoren eignen sich beispielsweise Seifen natürlicher oder synthetischer Herkunft, die einen hohen Anteil an Ci8~C24-Fettsäuren aufweisen. Geeignete nichttensid- artige Schauminhibitoren sind beispielsweise Organopolysiloxane und deren Gemische mit mikrofeiner, ggf. silanierter Kieselsäure sowie Paraffine, Wachse, Mikrokristallinwachse und deren Gemische mit silanierter Kiesel¬ säure oder Bistearylethylendiamid. Mit Vorteilen werden auch Gemische aus verschiedenen Schauminhibitoren verwendet, z.B. solche aus Silikonen, Pa¬ raffinen oder Wachsen. Vorzugsweise sind die Schauminhibitoren, insbeson¬ dere Silikon- oder Paraffin-haltige Schauminhibitoren, an eine granuläre, in Wasser lösliche bzw. dispergierbare Trägersubstanz gebunden. Insbeson¬ dere sind dabei Mischungen aus Paraffinen und Bistearylethylendiamiden bevorzugt.When used in machine washing processes, it can be advantageous to add conventional foam inhibitors to the agents. Suitable foam inhibitors are, for example, soaps of natural or synthetic origin, which have a high proportion of Ci8 ~ C24 fatty acids. Suitable non-surfactant-like foam inhibitors are, for example, organopolysiloxanes and their mixtures with microfine, optionally silanized silica, and paraffins, waxes, microcrystalline waxes and their mixtures with silanized silica or bistearylethylenediamide. Mixtures of different foam inhibitors are also used with advantages, e.g. those made of silicones, paraffins or waxes. The foam inhibitors, in particular silicone or paraffin-containing foam inhibitors, are preferably bound to a granular, water-soluble or dispersible carrier substance. Mixtures of paraffins and bistearylethylenediamides are particularly preferred.
Als Enzyme kommen solche aus der Klasse der Proteasen, Lipasen, Amylasen, Cellulasen bzw. deren Gemische in Frage. Besonders gut geeignet sind aus Bakterienstämmen oder Pilzen, wie Bacillus subtilis, Bacillus lichenifor- is und Streptomyces griseus gewonnene enzymatische Wirkstoffe. Vorzugs¬ weise werden Proteasen vom Subtilisin-Typ und insbesondere Proteasen, die aus Bacillus lentus gewonnen werden, eingesetzt. Dabei sind Enzymmischun¬ gen, beispielsweise aus Protease und A ylase oder Protease und Lipase oder Protease und Cellulase oder aus Cellulase und Lipase oder aus Protease, Amylase und Lipase oder Protease, Lipase und Cellulase, insbesondere je¬ doch Cellulase-haltige Mischungen von besonderem Interesse. Auch Peroxi- dasen oder Oxidasen haben sich in einigen Fällen als geeignet erwiesen. Die Enzyme können an Trägerstoffen adsorbiert und/oder in Hüllsubstanzen eingebettet sein, um sie gegen vorzeitige Zersetzung zu schützen. Der An¬ teil der Enzyme, Enzymmischungen oder Enzymgranulate kann beispielsweise etwa 0,1 bis 5 Gew.-%, vorzugsweise 0,1 bis etwa 2 Gew.-% betragen.Suitable enzymes are those from the class of proteases, lipases, amylases, cellulases or mixtures thereof. Enzymes obtained from bacterial strains or fungi such as Bacillus subtilis, Bacillus licheniformis and Streptomyces griseus are particularly suitable. Proteases of the subtilisin type and in particular proteases which are obtained from Bacillus lentus are preferably used. Of particular interest here are enzyme mixtures, for example of protease and aylase or protease and lipase or protease and cellulase or of cellulase and lipase or of protease, amylase and lipase or protease, lipase and cellulase, but in particular mixtures containing cellulase . Peroxi- In some cases, these or oxidases have proven to be suitable. The enzymes can be adsorbed on carriers and / or embedded in coating substances in order to protect them against premature decomposition. The proportion of the enzymes, enzyme mixtures or enzyme granules can be, for example, about 0.1 to 5% by weight, preferably 0.1 to about 2% by weight.
Als Stabilisatoren insbesondere für Perverbindungen und Enzyme kommen die Salze von Polyphosphonsäuren, insbesondere l-Hydroxyethan-l,l-diphosphon- säure (HEDP), Diethylentriaminpentamethylenphosphonsäure (DETPMP) oder Ethylendiamintetramethylenphosphonsäure in Betracht.The salts of polyphosphonic acids, in particular l-hydroxyethane-l, l-diphosphonic acid (HEDP), diethylenetriaminepentamethylenephosphonic acid (DETPMP) or ethylenediaminetetramethylenephosphonic acid are suitable as stabilizers, in particular for per compounds and enzymes.
Vergrauungsinhibitoren haben die Aufgabe, den von der Faser abgelösten Schmutz in der Flotte suspendiert zu halten und so das Vergrauen zu ver¬ hindern. Hierzu sind wasserlösliche Kolloide meist organischer Natur ge¬ eignet, beispielsweise die wasserlöslichen Salze polymerer Carbonsäuren, Leim, Gelatine, Salze von Ethercarbonsäuren oder Ethersulfonsäuren der Stärke oder der Cellulose oder Salze von sauren Schwefelsäureestern der Cellulose oder der Stärke. Auch wasserlösliche, saure Gruppen enthaltende Polyamide sind für diesen Zweck geeignet. Weiterhin lassen sich lösliche Stärkepräparate und andere als die obengenannten Stärkeprodukte verwenden, z.B. abgebaute Stärke, Aldehydstärken usw.. Auch Polyvinylpyrrolidon ist brauchbar. Bevorzugt werden jedoch Celluloseether, wie Cärboxymethylcellu¬ lose (Na-Salz), Methylcellulose, Hydroxyalkylcellulose und Mischether, wie Methylhydroxyethylcellulose, Methylhydroxypropylcellulose, Methylcarboxy- methylcellulose und deren Gemische, sowie Polyvinylpyrrolidon beispiels¬ weise in Mengen von 0,1 bis 5 Gew.-%, bezogen auf die Mittel, eingesetzt.Graying inhibitors have the task of keeping the dirt detached from the fiber suspended in the liquor and thus preventing graying. Water-soluble colloids of mostly organic nature are suitable for this, for example the water-soluble salts of polymeric carboxylic acids, glue, gelatin, salts of ether carboxylic acids or ether sulfonic acids of starch or cellulose or salts of acidic sulfuric acid esters of cellulose or starch. Water-soluble polyamides containing acidic groups are also suitable for this purpose. Soluble starch preparations and starch products other than those mentioned above can also be used, e.g. degraded starch, aldehyde starches, etc. Polyvinylpyrrolidone can also be used. However, preference is given to cellulose ethers, such as carboxymethyl cellulose (sodium salt), methyl cellulose, hydroxyalkyl cellulose and mixed ethers, such as methyl hydroxyethyl cellulose, methyl hydroxypropyl cellulose, methyl carboxymethyl cellulose and mixtures thereof, and also polyvinylpyrrolidone, for example in amounts of 0.1 to 5% by weight , based on the funds used.
Die Mittel können als optische Aufheller Derivate der Diaminostilbendi- sulfonsäure bzw. deren Alkalimetallsalze enthalten. Geeignet sind z.B. Salze der 4,4'-Bis(2-anilino-4-morpholino-l,3,5-triazinyl-6-amino)stil- ben-2,2'-disulfonsäure oder gleichartig aufgebaute Verbindungen, die an¬ stelle der Morpholino-Gruppe eine Diethanolaminogruppe, eine Methylamino- gruppe, eine Anilinogruppe oder eine 2-Methoxyethylaminogruppe tragen. Weiterhin können Aufheller vom Typ der substituierten Diphenylstyryle an¬ wesend sein, z.B. die Alkalisalze des 4,4'-Bis(2-sulfostyryl)-diphenyls, 4,4'-Bis(4-chlor-3-sulfostyryl)-diphenylsl oder 4-(4-Chlorstyryl)-4'-(2- sulfostyryl)-diphenyls. Auch Gemische der vorgenannten Aufheller können verwendet werden.As optical brighteners, the agents can contain derivatives of diaminostilbenedisulfonic acid or its alkali metal salts. Suitable are, for example, salts of 4,4'-bis (2-anilino-4-morpholino-l, 3,5-triazinyl-6-amino) stilbene-2,2'-disulfonic acid or compounds of the same structure which contain an replace the morpholino group with a diethanolamino group, a methylamino group, an anilino group or a 2-methoxyethylamino group. Brighteners of the substituted diphenylstyryl type may also be present, for example the alkali salts of 4,4'-bis (2-sulfostyryl) diphenyl, 4,4'-bis (4-chloro-3-sulfostyryl) diphenyl 1 or 4- (4-chlorostyryl) -4 '- (2- sulfostyryl) diphenyls. Mixtures of the aforementioned brighteners can also be used.
Die erfindungsgemäßen Tabletten - dabei ist es unwesentlich, ob es sich um Wasch- oder Reinigungsmittel-Tabletten oder um Additive zu Wasch- oder Reinigungsmittel handelt - können aus mehreren Teilkomponenten bestehen, wie diese in der Patentanmeldung W0-A-90/02165 beschrieben werden. So ist es also bevorzugt, daß die Tabletten dadurch hergestellt werden, daß man mindestens 2 zuvor hergestellte pulverförmige bis granuläre Komponenten vermischt und dieses Gemisch dann verpreßt, wobei in der einen Komponente die Gesamtmenge der anionischen Tenside und in der anderen Komponente 75 bis 100 Gew.-% der Gesamtmenge der nichtionischen Tenside enthalten ist. Auch weitere Teilkomponenten können zur Herstellung der Tabletten herange¬ zogen werden, diese können insbesondere Bleichmittel und/oder Bleichakti¬ vatoren oder beispielsweise auch Enzyme, Entschäumer und Duftstoffe ent¬ halten.The tablets according to the invention - it is immaterial whether it is detergent tablets or additives to detergents or cleaning agents - can consist of several sub-components, as described in patent application WO-A-90/02165. So it is preferred that the tablets are produced by mixing at least 2 previously prepared powdery to granular components and then compressing this mixture, the total amount of anionic surfactants in one component and 75 to 100% by weight in the other component. -% of the total amount of nonionic surfactants is included. Other subcomponents can also be used to produce the tablets, these can in particular contain bleaching agents and / or bleach activators or, for example, also enzymes, defoamers and fragrances.
Möglich ist es aber auch, daß die verschiedenen Komponenten nicht zu einer einheitlichen Tablette verpreßt werden, sondern daß Tabletten erhalten werden, die mehrere Schichten, also mindestens 2 Schichten aufweisen. Da¬ bei ist auch möglich, daß diese verschiedenen Schichten unterschiedliche Lösegeschwindigkeiten aufweisen. Hieraus können vorteilhafte anwendungs¬ technische Eigenschaften der Tabletten resultieren. Falls beispielsweise Komponenten in den Tabletten enthalten sind, die sich wechselseitig ne¬ gativ beeinflussen, so ist es möglich, die eine Komponente in der schnell¬ löslichen Schicht zu integrieren und die andere Komponente in eine lang¬ samer lösliche Schicht einzuarbeiten, so daß die erste Komponente bereits abreagiert hat, wenn die zweite in Lösung geht. In einer weiteren bevor¬ zugten Auführungsfor der Erfindung besteht eine Tablette aus mindestens drei Schichten, also zwei äußeren und mindestens einer inneren Schicht, wobei mindestens in einer der inneren Schichten ein Peroxy-Bleichmittel enthalten ist, die beiden äußeren Schichten jedoch frei von Peroxy-Bleich¬ mittel sind. Weiterhin ist es so auch möglich, Peroxy-Bleichmittel und gegebenenfalls vorhandene Bleichaktivatoren und/oder Enzyme räumlich in einer Tablette voneinander zu trennen. Derartige mehrschichtige Tabletten weisen den Vorte l auf, daß sie nicht nur über eine Einspülkammer oder über eine Dosiervorrichtung, welche in die Waschflotte gegeben wird, ein¬ gesetzt werden können; vielmehr ist es in solchen Fällen auch möglich, die Tablette im direkten Kontakt zu den Textilien in die Maschine zu geben, ohne daß Verfleckungen durch Bleichmittel und dergleichen zu befürchten wären.However, it is also possible that the various components are not pressed into a uniform tablet, but that tablets are obtained which have several layers, that is to say at least 2 layers. It is also possible for these different layers to have different dissolution rates. This can result in advantageous application properties of the tablets. If, for example, components are contained in the tablets which mutually influence one another negatively, it is possible to integrate one component in the rapidly soluble layer and to incorporate the other component in a more slowly soluble layer, so that the first Component has already reacted when the second goes into solution. In a further preferred embodiment of the invention, a tablet consists of at least three layers, that is to say two outer and at least one inner layer, wherein at least one of the inner layers contains a peroxy bleach, but the two outer layers are free of peroxy bleach ¬ are medium. Furthermore, it is also possible to spatially separate peroxy bleaching agents and any bleach activators and / or enzymes that may be present in one tablet. Such multilayer tablets have the advantage that they not only have a dispenser or can be inserted via a metering device which is added to the wash liquor; rather, it is also possible in such cases to put the tablet in direct contact with the textiles in the machine without fear of bleaching and the like.
Letztendlich wird auch ein Waschverfahren beansprucht, bei dem für einen einzigen Waschgang mehrere, mindestens aber zwei Tabletten mit gleicher oder unterschiedlicher Zusammensetzung eingesetzt werden. Insbesondere ist dabei eine Kombination von Tabletten nach dem Baukastenprinzip möglich. Dies bedeutet, daß in einem Waschgang beispielsweise eine Tablette als Basiswaschmittel eingesetzt wird, wobei diese Tablette insbesondere Ten¬ side und die erfindungsgemäß eingesetzten Silikate sowie weitere Bestand¬ teile von üblichen Wasch- oder Reinigungsmitteln enthält, aber frei von Bleichmitteln ist. Zusätzlich zu dieser Tablette können dann eine Wasser¬ enthärtungstablette und/oder eine Bleichtablette angewendet werden. Der Zusatz einer Wasserenthärtungstablette kann in Gegenden mit einer sehr hohen Wasserhärte im Leitungswasser hilfreich sein, während der Einsatz einer zusätzlichen Bleichtablette von der Art der zu waschenden Textilien und der Verfleckungen abhängig gemacht werden kann.Ultimately, a washing process is also claimed in which several, but at least two tablets with the same or different composition are used for a single wash cycle. In particular, a combination of tablets according to the modular principle is possible. This means that, for example, one tablet is used as the basic detergent in one wash cycle, this tablet containing in particular tenides and the silicates used according to the invention and further constituents of conventional detergents or cleaning agents, but is free from bleaching agents. In addition to this tablet, a water softening tablet and / or a bleaching tablet can then be used. The addition of a water softening tablet can be helpful in areas with very high water hardness in tap water, while the use of an additional bleaching tablet can be made dependent on the type of textiles to be washed and the stains.
Die Tablette(n) kann (können) auch mittels eines Dosierbehälters direkt zu Beginn des Waschvorgangs auf die Wäsche in der Waschmaschine positioniert werden. Da am Anfang des Waschvorgangs mit wenig Feuchtigkeit hohe Konzen¬ trationen an Aktivsubstanzen vorhanden sein können, ist eine Fleckenbil¬ dung auf der Wäsche (z. B. durch Bleichmitteleinwirkung) nicht auszu¬ schließen. Dieser "Spottingeffekt" wird beispielsweise dadurch vermieden, indem der Dosierbehälter korbartig ausgebildet wird. Im Innern des Korbs befindet sich ein wasserdurchlässiger sieb- oder netzartiger Aufnahmebe¬ hälter für die Tabletten. Der äußere Korb verhindert das direkte Aufliegen des Formkörpers auf den Textilien. Dabei ist es bevorzugt, daß der sieb- oder netzartige Aufnahmebehälter relativ engmaschig ist, so daß Bruch¬ stücke aus dem Korb in die Waschflotte insbesondere erst dann übergehen, wenn ihr maximaler Teilchendurchmesser deutlich kleiner als 10 mm und vor¬ teilhafterweise kleiner als 5 mm ist. BeispieleThe tablet (s) can also be positioned on the laundry in the washing machine directly at the beginning of the washing process by means of a dosing container. Since high concentrations of active substances can be present at the beginning of the washing process with little moisture, the formation of stains on the laundry (for example due to the action of bleach) cannot be ruled out. This "spotting effect" is avoided, for example, by designing the dosing container like a basket. In the interior of the basket there is a water-permeable sieve or net-like receptacle for the tablets. The outer basket prevents the molded body from lying directly on the textiles. It is preferred that the sieve-like or mesh-like receptacle is relatively narrow-meshed, so that fragments from the basket only pass into the wash liquor when their maximum particle diameter is significantly less than 10 mm and advantageously less than 5 mm . Examples
Die Tabletten der nachfolgenden Beispiele wurden derart hergestellt, daß zunächst die entsprechenden Bestandteile gemischt und anschließend in ei¬ ner hydraulisch arbeitenden Presse (Firma Kürschner, Bundesrepublik Deutschland) bei Preßdrucken im Bereich von etwa 10 bis 150 bar herge¬ stellt wurden.The tablets of the following examples were produced in such a way that the corresponding constituents were first mixed and then produced in a hydraulically operating press (company Kürschner, Federal Republic of Germany) at pressures in the range from about 10 to 150 bar.
Beispiel 1: Waschmittel-Tablette ohne ZeolithExample 1: Detergent tablet without zeolite
Eine Mischung aus 8,6 Gew.-% Ci2-Ci8-Fettalkoholsulfat, 6,5 Gew.-% C12- Ciβ-Fettalkohol mit 5 EO, 1 Gew.-% Ci2-Ci8-Natriumfettsäureseife, 29 Gew.-% kristallinem schichtförmigen Natriumdisilikat (SKS-6(R), Handels¬ produkt der Hoechst AG, Bundesrepublik Deutschland), 5,2 Gew.-% Natrium- carbonat, 0,5 Gew.-% amorphes Natriumsilikat (Na2θ:Siθ2 von 1:3,0), 5 Gew.-% terpolymeres Salz aus Acrylsäure, Maleinsäure und Vinylalkohol, hergestellt gemäß der Lehre der deutschen Patentanmeldung DE-A-4300772.4, 20,5 Gew.-% Natriumperboratmonohydrat, 6,4 Gew.-% eines TAED-Granulats, 1 Gew.-% einer granulären Protease, 14 Gew.-% Natriumsul¬ fat, 1 Gew.-% Methylhydroxypropylcellulose, Salze aus Lösungen und 0,4 Gew.-% Wasser wurde zu einer Tablette verpreßt. Das Wasser stammte aus den eingesetzten Rohstoffen und wurde nicht zusätzlich zugesetzt. Das Fettal¬ koholsulfat wurde über ein Compound in die Mischung eingebracht, das gemäß der Lehre der deutschen Patentanmeldung DE-A-4127323 hergestellt worden war. Das SKS-6( ) wurde mit dem Niotensid vorgemischt und dann zu den übrigen Bestandteilen gegeben. Eine Tablette reichte als alleiniges Wasch¬ mittel für einen Waschgang aus und besaß ein Gewicht von 80 g. Sie besaß einen Durchmesser von 38 mm und eine Höhe von 15 mm.A mixture of 8.6% by weight of Ci2-Ci8 fatty alcohol sulfate, 6.5% by weight of C12-Ciβ fatty alcohol with 5 EO, 1% by weight of Ci2-Ci8 sodium fatty acid soap, 29% by weight of crystalline layer Sodium disilicate (SKS-6 ( R ), commercial product of Hoechst AG, Federal Republic of Germany), 5.2% by weight sodium carbonate, 0.5% by weight amorphous sodium silicate (Na2θ: Siθ2 of 1: 3.0 ), 5% by weight of terpolymeric salt from acrylic acid, maleic acid and vinyl alcohol, prepared according to the teaching of German patent application DE-A-4300772.4, 20.5% by weight of sodium perborate monohydrate, 6.4% by weight of TAED granules, 1% by weight of a granular protease, 14% by weight of sodium sulphate, 1% by weight of methylhydroxypropyl cellulose, salts from solutions and 0.4% by weight of water were pressed into a tablet. The water came from the raw materials used and was not added. The fatty alcohol sulfate was introduced into the mixture via a compound which had been prepared in accordance with the teaching of the German patent application DE-A-4127323. The SKS-6 () was premixed with the nonionic surfactant and then added to the remaining ingredients. One tablet was sufficient as the sole detergent for one wash cycle and had a weight of 80 g. It had a diameter of 38 mm and a height of 15 mm.
Beispiel 2: Waschmittel-Tablette mit ZeolithExample 2: Detergent tablet with zeolite
Es wurde eine Tablette aus einer Mischung hergestellt, welche 8 Gew.-% Ci2-Ci8-Fettalkoholsulfat, 6 Gew.-% Ci2-Ci8-Fettalkohol mit 5 E0, 1 Gew.-% Ci2-Ci8-Natriumfettsäureseife, 11,5 Gew.-% kristallines schichtförmiges Natriumdisilikat (SKS-6(R), Handelsprodukt der Hoechst AG, Bundesrepublik Deutschland), 15 Gew.-% Zeolith (bezogen auf wasserfreie Aktivsubstanz), 5 Gew.-% Natriumcarbonat, 0,5 Gew.-% amorphes Natriumsilikat (Na2θ:Siθ2 1:3,0), 9 Gew.-% Trinatriumcitrat-dihydrat, 20 Gew.-% Natriumperborat- tetrahydrat, 6 Gew.-% eines TAED-Granulats, 1 Gew.-% einer granulären Pro¬ tease, 9 Gew.-% Natriumsulfat, 1 Gew.-% Methylhydroxypropylcellulose, 0,5 Gew.-% Carboxymethylcellulose (CMC), 0,6 Gew.-% Bentonit, 0,15 Gew.-% eines granulären Schauminhibitors auf Silikonölbasis, 0,2 Gew.-% Parfüm, 0,15 Gew.-% optischen Aufheller, Salze aus Lösungen und 4,4 Gew.-% Wasser enthielten. Das Wasser stammte aus den eingesetzten Rohstoffen, insbeson¬ dere aus dem eingesetzten pulverförmigen Zeolith, und wurde nicht zusätz¬ lich hinzugegeben. Das Fettalkoholsulfat wurde wiederum über ein Compound in die Mischung eingebracht, das gemäß der Lehre der deutschen Patentan¬ meldung DE-A-41 27 323 hergestellt worden war. Der Zeolith wurde in Form eines sprühgetrockneten Pulvers eingesetzt, wobei die sprühzutrocknende Aufschlämmung zusätzlich geringe Mengen an Niotensid, CMC, Natronlauge und den Bentonit enthielt und zusätzlich mit dem restlichen Niotensid beauf¬ schlagt wurde. Eine Tablette reichte als alleiniges Waschmittel für einen Waschgang aus und besaß ein Gewicht von 80 g. Sie besaß einen Durchmesser von 38 mm und eine Höhe von 15 mm.A tablet was produced from a mixture containing 8% by weight of Ci2-Ci8 fatty alcohol sulfate, 6% by weight of Ci2-Ci8 fatty alcohol with 5E0, 1% by weight of Ci2-Ci8 sodium fatty acid soap, 11.5% by weight % crystalline layered sodium disilicate (SKS-6 ( R ), commercial product of Hoechst AG, Federal Republic of Germany), 15% by weight zeolite (based on anhydrous active substance), 5 % By weight sodium carbonate, 0.5% by weight amorphous sodium silicate (Na2θ: Siθ2 1: 3.0), 9% by weight trisodium citrate dihydrate, 20% by weight sodium perborate tetrahydrate, 6% by weight one TAED granules, 1% by weight of a granular protease, 9% by weight sodium sulfate, 1% by weight methyl hydroxypropyl cellulose, 0.5% by weight carboxymethyl cellulose (CMC), 0.6% by weight bentonite, 0.15% by weight of a granular foam inhibitor based on silicone oil, 0.2% by weight of perfume, 0.15% by weight of optical brightener, salts from solutions and 4.4% by weight of water. The water came from the raw materials used, in particular from the powdered zeolite used, and was not added. The fatty alcohol sulfate was again introduced into the mixture via a compound which had been produced in accordance with the teaching of the German patent application DE-A-41 27 323. The zeolite was used in the form of a spray-dried powder, the slurry to be spray-dried additionally containing small amounts of nonionic surfactant, CMC, sodium hydroxide solution and the bentonite and the remaining nonionic surfactant was additionally applied. One tablet was sufficient as the sole detergent for one wash cycle and had a weight of 80 g. It had a diameter of 38 mm and a height of 15 mm.
Beispiel 3: Wasserenthärter-TabletteExample 3: Water softener tablet
Es wurde eine Tablette aus einer Mischung hergestellt, welche 5,7 Gew.-% Natriumcarbonat, 67 Gew.-% SKS-δ(R), 1 Gew.-% Methylhydroxypropylcellu¬ lose, 16 Gew.-% Trinatriumcitrat-dihydrat, 8 Gew.-% eines terpolymeres Salz aus Acrylsäure, Maleinsäure und Vinylalkohol, hergestellt gemäß der Lehre der deutschen Patentanmeldung P 4300 772.4 und anschließender Sprühtrocknung einer 38 Gew.-% wäßrigen Lösung, 0,72 Gew.-% Wasser, das aus den eingesetzten Rohstoffen und nicht zusätzlich hinzugegeben wurde, sowie 0,5 Gew.-% Natriumsulfat und Rest weitere Salze aus den Rohstoffen enthielt. Die Tablette besaß einen Durchmesser von 23 mm, eine Höhe von 10 mm und ein Gewicht von 20 g.A tablet was produced from a mixture which contained 5.7% by weight sodium carbonate, 67% by weight SKS-δ ( R ), 1% by weight methylhydroxypropylcellulose, 16% by weight trisodium citrate dihydrate, 8 % By weight of a terpolymeric salt of acrylic acid, maleic acid and vinyl alcohol, prepared according to the teaching of German patent application P 4300 772.4 and subsequent spray drying of a 38% by weight aqueous solution, 0.72% by weight of water, which is obtained from the raw materials used and was not additionally added, and contained 0.5% by weight sodium sulfate and the rest of further salts from the raw materials. The tablet had a diameter of 23 mm, a height of 10 mm and a weight of 20 g.
Beispiel 4: BleichtabletteExample 4: Bleaching tablet
Es wurde eine Tablette aus einer Mischung hergestellt, welche 58 Gew.-%A tablet was made from a mixture containing 58% by weight
SKS-6(R), 30 Gew.-% Perboratmonohydrat, 10,5 Gew.-% eines TAED-Granulats und 1 Gew.-% Methylhydroxypropylcellulose enthielt. Die Tablette besaß einen Durchmesser von 23 mm, eine Höhe von 10 mm und ein Gewicht von 20 g.SKS-6 ( R ), 30% by weight perborate monohydrate, 10.5% by weight of a TAED granulate and 1% by weight of methyl hydroxypropyl cellulose. The tablet had a diameter of 23 mm, a height of 10 mm and a weight of 20 g.
Beispiel 5: Basiswaschmittel-TabletteExample 5: Basic detergent tablet
Es wurde eine Tablette aus einer Mischung hergestellt, welche 16,5 Gew.-% Ci2-Ci8-Fettalkoholsulfat, 12,4 Gew.-% Ci2-Ci8-Fettalkohol mit 5 EO, 1,5 Gew.-% Ci2-Ci8-Natriumfettsäureseife, 12 Gew.-% kristallines schichtförmi- ges Natriumdisilikat (SKS-6(R), Handelsprodukt der Hoechst AG, Bundesrepu¬ blik Deutschland), 20 Gew.-% Zeolith (bezogen auf wasserfreie Aktivsub¬ stanz), 2 Gew.-% Sokalan CPδ(R), 10 Gew.-% Natriumcarbonat, 0,5 Gew.-% amorphes Natriumsilikat (Na2θ:Siθ2 1:3,0), 1,5 Gew.-% einer granulären Protease, 10 Gew.-% Natriumsulfat, 1 Gew.-% Methylhydroxypropylcellulose, 1 Gew.-% Carboxymethylcellulose (CMC), 1,3 Gew.- Bentonit, 0,7 Gew.-% eines granulären Schauminhibitors auf Silikonölbasis, 0,2 Gew.-% Parfüm, 0,15 Gew.-% optischen Aufheller, Salze aus den eingesetzen Rohstoffen und 6,2 Gew.-% Wasser enthielten. Das Wasser stammte aus den eingesetzten Roh¬ stoffen, insbesondere aus dem eingesetzten pulverförmigen Zeolith, und wurde nicht zusätzlich hinzugegeben. Das Fettalkoholsulfat wurde wiederum über ein Compound in die Mischung eingebracht, das gemäß der Lehre der deutschen Patentanmeldung DE-A-41 27323 hergestellt worden war. Der Zeolith wurde in Form eines sprühgetrockneten Pulvers eingesetzt, wobei die sprühzutrocknende Aufschlämmung zusätzlich geringe Mengen an Nioten¬ sid, CMC, Natronlauge und den Bentonit enthielt. Eine Tablette besaß ein Gewicht von 40 g. Sie besaß einen Durchmesser von 35 mm und eine Höhe von 10 mm.A tablet was produced from a mixture comprising 16.5% by weight of Ci2-Ci8 fatty alcohol sulfate, 12.4% by weight of Ci2-Ci8 fatty alcohol with 5 EO, 1.5% by weight of Ci2-Ci8- Sodium fatty acid soap, 12% by weight of crystalline layered sodium disilicate (SKS-6 ( R ), commercial product of Hoechst AG, Federal Republic of Germany), 20% by weight of zeolite (based on anhydrous active substance), 2% by weight % Sokalan CPδ ( R ), 10% by weight sodium carbonate, 0.5% by weight amorphous sodium silicate (Na2θ: Siθ2 1: 3.0), 1.5% by weight of a granular protease, 10% by weight Sodium sulfate, 1% by weight methyl hydroxypropyl cellulose, 1% by weight carboxymethyl cellulose (CMC), 1.3% by weight bentonite, 0.7% by weight of a granular foam inhibitor based on silicone oil, 0.2% by weight perfume, 0 , 15 wt .-% optical brightener, salts from the raw materials used and 6.2 wt .-% water. The water came from the raw materials used, in particular from the powdered zeolite used, and was not additionally added. The fatty alcohol sulfate was again introduced into the mixture via a compound which had been prepared in accordance with the teaching of the German patent application DE-A-41 27323. The zeolite was used in the form of a spray-dried powder, the slurry to be spray-dried additionally containing small amounts of Nioten sid, CMC, sodium hydroxide solution and the bentonite. One tablet weighed 40 g. It had a diameter of 35 mm and a height of 10 mm.
Beispiel 6: Baukastensystem aus TablettenExample 6: Modular system made of tablets
Jeweils 1 Tablette, hergestellt gemäß den Beispielen 3, 4 und 5, wurde in einem Waschgang eingesetzt. 1 tablet each, produced according to Examples 3, 4 and 5, was used in one wash.

Claims

Patentansprüche claims
1. Tablette, enthaltend Buildersubstanzen, dadurch gekennzeichnet, daß diese Tablette amorphe, teilkristalline und/oder kristalline schicht¬ förmige Natriumsilikate der Formel Na2Sixθ2x+ι# H2θ in Mengen von 2 bis 100 Gew.-% enthält und x eine Zahl von 1,9 bis 4 und y eine Zahl von 0 bis 20 ist und bevorzugte Werte für x 2, 3 oder 4 sind, mit der Maßgabe, daß die Tablette Wasser nur in den Mengen enthält, daß das maximale theoretische Wasserbindevermögen der Inhaltsstoffe nicht überschritten wird.1. tablet containing builder substances, characterized in that this tablet contains amorphous, partially crystalline and / or crystalline layered sodium silicates of the formula Na2Si x θ2 x + ι # H2θ in amounts of 2 to 100% by weight and x contains a number of 1 , 9 to 4 and y is a number from 0 to 20 and are preferred values for x 2, 3 or 4, with the proviso that the tablet contains water only in the amounts that the maximum theoretical water binding capacity of the ingredients is not exceeded.
2. Tablette nach Anspruch 1, dadurch gekennzeichnet, daß sie entweder kristalline schichtförmige Natriumsilikate oder röntgenamorphe Sili¬ kate oder daß sie kristalline schichtförmige Natriumsilikate und rönt¬ genamorphe Silikate im Gewichtsverhältnis von 10:1 bis 1:10 enthalten.2. Tablet according to claim 1, characterized in that it contains either crystalline layered sodium silicates or X-ray amorphous silicates or that they contain crystalline layered sodium silicates and X-ray amorphous silicates in a weight ratio of 10: 1 to 1:10.
3. Tablette nach Anspruch 1 oder 2, dadurch gekennzeichnet, daß sie frei ist von üblichen amorphen Silikaten des Wasserglas-Typs.3. Tablet according to claim 1 or 2, characterized in that it is free of conventional amorphous silicates of the water glass type.
4. Tablette nach Anspruch 1 oder 2, dadurch gekennzeichnet, daß sie amor¬ phe Silikate des Wasserglas-Typs in Kombination mit kristallinen schichtförmigen Natriumsilikaten und/oder röntgenamorphen Silikaten enthält, wobei der Gehalt an amorphen Silikaten des Wasserglas-Typs vorzugsweise 20 Gew.-% und insbesondere 15 Gew.-%, jeweils bezogen auf die Gesamtmenge der vorhandenen Silikate in der Tablette, nicht über¬ steigt.4. Tablet according to claim 1 or 2, characterized in that it contains amorphous silicates of the water glass type in combination with crystalline layered sodium silicates and / or X-ray amorphous silicates, the content of amorphous silicates of the water glass type preferably being 20% by weight. % and in particular 15% by weight, based in each case on the total amount of silicates present in the tablet, does not exceed.
5. Tablette nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, daß sie in übertrockneter Form vorliegt.5. Tablet according to one of claims 1 to 4, characterized in that it is in over-dried form.
6. Tablette nach einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, daß sie 5 bis 60 Gew.-%, vorzugsweise 10 bis 40 Gew.-% amorphe, teilkri¬ stalline und/oder kristalline schichtförmige Natriumsilikate enthält.6. Tablet according to one of claims 1 to 5, characterized in that it contains 5 to 60 wt .-%, preferably 10 to 40 wt .-% amorphous, partially crystalline and / or crystalline layered sodium silicates.
7. Tablette nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, daß sie Sprengmittel und/oder Tablettierhilfsmittel enthält. 7. Tablet according to one of claims 1 to 6, characterized in that it contains disintegrants and / or tableting aids.
8. Tablette nach einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, daß sie 0,5 bis 98 Gew.-% wasserhaltigen Zeolith und/oder Phosphate ent¬ hält, wobei der Gehalt an Phosphaten vorzugsweise auf maximal 50 Gew.-% und insbesondere auf maximal 30 Gew.-% beschränkt ist.8. Tablet according to one of claims 1 to 7, characterized in that it contains 0.5 to 98% by weight of water-containing zeolite and / or phosphates, the content of phosphates preferably being at most 50% by weight and in particular is limited to a maximum of 30% by weight.
9. Tablette nach einem der Ansprüche 1 bis 8, dadurch gekennzeichnet, daß sie bis zu 40 Gew.-% Aniontenside und/oder Seifen enthält.9. Tablet according to one of claims 1 to 8, characterized in that it contains up to 40 wt .-% anionic surfactants and / or soaps.
10. Tablette nach einem der Ansprüche 1 bis 9, dadurch gekennzeichnet, daß sie bis zu 20 Gew.-% nichtionische Tenside enthält.10. Tablet according to one of claims 1 to 9, characterized in that it contains up to 20 wt .-% nonionic surfactants.
11. Tablette nach einem der Ansprüche 1 bis 10, dadurch gekennzeichnet, daß sie mindestens 2 zuvor hergestellte pulverförmige bis granuläre Komponenten enthält, von denen die erste die Gesamtmenge der anio¬ nischen Tenside und die zweite 75 bis 100 Gew.-% der Gesamtmenge der nichtionischen Tenside enthält.11. Tablet according to one of claims 1 to 10, characterized in that it contains at least 2 previously prepared powdery to granular components, of which the first is the total amount of anionic surfactants and the second 75 to 100 wt .-% of the total amount of contains nonionic surfactants.
12. Tablette nach einem der Ansprüche 1 bis 11, dadurch gekennzeichnet, daß sie aus mindestens 2 Schichten besteht, die gegebenenfalls unter¬ schiedliche Lösegeschwindigkeiten aufweisen.12. Tablet according to one of claims 1 to 11, characterized in that it consists of at least 2 layers, which may have different dissolving speeds.
13. Tablette nach einem der Ansprüche 1 bis 12, dadurch gekennzeichnet, daß sie aus mindestens 3 Schichten besteht und mindestens in einer der inneren Schichten ein Peroxy-Bleichmittel enthält.13. Tablet according to one of claims 1 to 12, characterized in that it consists of at least 3 layers and contains at least one of the inner layers of a peroxy bleach.
14. Wasserenthärtungstablette nach einem der Ansprüche 1 bis 13, dadurch gekennzeichnet, daß sie zu 20 bis 80 Gew.-%, vorzugsweise 30 bis 60 Gew.-% aus amorphen, teilkristallinen und/oder kristallinen schicht¬ förmigen Natriums likaten der angegebenen Formel, zu 0 bis 80 Gew.-%, vorzugsweise 5 bis 80 Gew.-% und insbesondere 10 bis 60 Gew.-% aus wasserhaltigem Zeolith und/oder Phosphat, zu 0 bis 50 Gew.-%, vorzugs¬ weise 0,5 bis 30 Gew.-% und insbesondere 2 bis 20 Gew.-% aus Polycarb¬ oxylaten, zu 0 bis 15 Gew.-%, vorzugsweise zu 0,5 bis 12 Gew.-% und insbesondere zu 1 bis 10 Gew.-% aus polymeren Polycarboxylaten sowie zu 0 bis 30 Gew.-%, vorzugsweise 0,5 bis 20 Gew.-% und insbesondere zu 2 bis 15 Gew.-% aus Aniontensiden, Niotensiden, alkalisch oder neutral reagierenden anorganischen Salzen oder Mischungen aus diesen besteht.14. Water softening tablet according to one of claims 1 to 13, characterized in that it contains 20 to 80% by weight, preferably 30 to 60% by weight, of amorphous, partially crystalline and / or crystalline layered sodium likates of the formula given, 0 to 80% by weight, preferably 5 to 80% by weight and in particular 10 to 60% by weight of water-containing zeolite and / or phosphate, 0 to 50% by weight, preferably 0.5 to 30% by weight and in particular 2 to 20% by weight of polycarboxylates, 0 to 15% by weight, preferably 0.5 to 12% by weight and in particular 1 to 10% by weight polymeric polycarboxylates and 0 to 30 wt .-%, preferably 0.5 to 20 wt .-% and in particular zu 2 to 15 wt .-% of anionic surfactants, nonionic surfactants, alkaline or neutral reacting inorganic salts or mixtures of these.
15. Bleichende Tablette nach einem der Ansprüche 1 bis 13, dadurch gekenn¬ zeichnet, daß sie 20 bis 80 Gew.-%, vorzugsweise 30 bis 60 Gew.-% aus amorphen, teilkristallinen und/oder kristallinen schichtförmigen Na¬ triumsilikaten der angegebenen Formel und 20 bis 50, vorzugsweise 25 bis 45 Gew.-% Peroxy-Bleichmittel, aber keinen Zeolith enthält.15. Bleaching tablet according to one of claims 1 to 13, characterized gekenn¬ characterized in that it 20 to 80 wt .-%, preferably 30 to 60 wt .-% of amorphous, partially crystalline and / or crystalline layered sodium silicates of the formula given and 20 to 50, preferably 25 to 45% by weight peroxy bleach, but containing no zeolite.
16. Verfahren zur Herstellung von Tabletten gemäß einem der Ansprüche 1 bis 15, dadurch gekennzeichnet, daß die zur Verpressung vorgesehenen Vorgemische durch Vermischen der einzelnen Inhaltsstoffe, die wenig¬ stens anteilsweise in vorkonfektionierter Form als granuläres Compound vorliegen, hergestellt werden.16. A process for the production of tablets according to one of claims 1 to 15, characterized in that the premixes intended for compression are produced by mixing the individual ingredients, which are at least partially present in pre-assembled form as a granular compound.
17. Verfahren nach Anspruch 16, dadurch gekennzeichnet, daß die Verpres¬ sung ohne Zugabe von Wasser erfolgt.17. The method according to claim 16, characterized in that the pressing takes place without the addition of water.
18. Verfahren nach Anspruch 16 oder 17, dadurch gekenzeichnet, daß walzen- kompaktierte kristalline schichtförmige Natriumdisilikate, die gegebe¬ nenfalls mit flüssigen bis wachsartigen Komponenten, beispielsweise mit nichtionischen Tensiden imprägniert sind, als granuläres Compound eingesetzt werden.18. The method according to claim 16 or 17, characterized in that roller-compacted crystalline layered sodium disilicates, which are optionally impregnated with liquid to wax-like components, for example with nonionic surfactants, are used as a granular compound.
19. Verfahren nach einem der Ansprüche 16 bis 18, dadurch gekennzeichnet, daß vor der Verpressung mindestens 2 pulverförmige bis granuläre Com¬ pounds hergestellt werden, von denen die erste die Gesamtmenge der an¬ ionischen Tenside und die zweite 75 bis 100 Gew.-% der Gesamtmenge der nichtionischen Tenside enthält.19. The method according to any one of claims 16 to 18, characterized in that at least 2 pulverulent to granular compounds are produced before the pressing, the first of which the total amount of the anionic surfactants and the second of 75 to 100% by weight. contains the total amount of nonionic surfactants.
20. Verfahren nach einem der Ansprüche 16 bis 19, dadurch gekennzeichnet, daß eine Tablette aus mindestens 2 Schichten hergestellt wird, die gegebenenfalls unterschiedliche Lösegeschwindigkeiten aufweisen. 20. The method according to any one of claims 16 to 19, characterized in that a tablet is produced from at least 2 layers, which may have different dissolution rates.
21. Verfahren nach einem der Ansprüche 16 bis 20, dadurch gekennzeichnet, daß eine Tablette aus mindestens 3 Schichten hergestellt wird, wobei mindestens eine der inneren Schichten ein Peroxy-Bleichmittel enthält.21. The method according to any one of claims 16 to 20, characterized in that a tablet is produced from at least 3 layers, at least one of the inner layers containing a peroxy bleach.
22. Waschverfahren, bei dem mindestens zwei Tabletten gemäß einem der An¬ sprüche 1 bis 15 mit gleicher oder unterschiedlicher Zusammensetzung in einem einzigen Waschgang eingesetzt werden, wobei ein Baukasten¬ system aus einer Basiswaschmitteltablette und einer Wasserenthärtungs¬ tablette und/oder einer Bleichtablette bevorzugt ist.22. Washing process in which at least two tablets according to one of claims 1 to 15 with the same or different composition are used in a single washing cycle, a modular system comprising a basic detergent tablet and a water softening tablet and / or a bleaching tablet being preferred .
23. Waschverfahren, bei dem mindestens 1 Tablette gemäß einem der An¬ sprüche 1 bis 15 in einem Waschvorgang eingesetzt wird, wobei die Ta¬ blette^) mittels eines Dosierbehälters direkt zu Beginn des Wasch¬ vorgangs auf die Wäsche in der Waschmaschine positioniert wird (wer¬ den). 23. Washing process in which at least 1 tablet according to one of claims 1 to 15 is used in a washing process, the tablet being positioned on the laundry in the washing machine directly at the beginning of the washing process by means of a metering container ( be¬).
EP95908245A 1994-02-10 1995-02-01 Bleaching tablet with builder substances Expired - Lifetime EP0743978B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP99115247A EP0965565A1 (en) 1994-02-10 1995-02-01 Water-softening tablet

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4404279A DE4404279A1 (en) 1994-02-10 1994-02-10 Tablet with builder substances
DE4404279 1994-02-10
PCT/EP1995/000359 WO1995021908A1 (en) 1994-02-10 1995-02-01 Tablet with builder substances

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP99115247A Division EP0965565A1 (en) 1994-02-10 1995-02-01 Water-softening tablet

Publications (2)

Publication Number Publication Date
EP0743978A1 true EP0743978A1 (en) 1996-11-27
EP0743978B1 EP0743978B1 (en) 2001-04-25

Family

ID=6509983

Family Applications (2)

Application Number Title Priority Date Filing Date
EP95908245A Expired - Lifetime EP0743978B1 (en) 1994-02-10 1995-02-01 Bleaching tablet with builder substances
EP99115247A Ceased EP0965565A1 (en) 1994-02-10 1995-02-01 Water-softening tablet

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP99115247A Ceased EP0965565A1 (en) 1994-02-10 1995-02-01 Water-softening tablet

Country Status (6)

Country Link
US (1) US5900399A (en)
EP (2) EP0743978B1 (en)
AT (1) ATE200794T1 (en)
DE (2) DE4404279A1 (en)
ES (1) ES2157320T3 (en)
WO (1) WO1995021908A1 (en)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435632A1 (en) * 1994-10-06 1996-04-11 Henkel Kgaa Detergent or cleaning agent with amorphous silicate builder substances
DE19601840A1 (en) * 1996-01-19 1997-07-24 Henkel Kgaa Process for the preparation of detergent tablets
AU7006996A (en) * 1996-08-07 1998-02-25 Procter & Gamble Company, The Laundry bar compositions
US6177398B1 (en) * 1996-12-12 2001-01-23 The Procter & Gamble Company Process for making tabletted detergent compositions
DE19709411A1 (en) * 1997-03-07 1998-09-10 Henkel Kgaa Detergent tablets
DE19758811B4 (en) 1997-03-11 2008-12-18 Henkel Ag & Co. Kgaa Detergent pellet
DE19710254A1 (en) * 1997-03-13 1998-09-17 Henkel Kgaa Shaped or active cleaning moldings for household use
DE19714657C1 (en) * 1997-04-09 1999-01-07 Benckiser Nv Water soluble, water softening builder
GB9711829D0 (en) 1997-06-06 1997-08-06 Unilever Plc Detergent compositions
ZA984570B (en) 1997-06-06 1999-11-29 Unilever Plc Cleaning compositions.
HUP0004038A3 (en) * 1997-10-22 2001-11-28 Unilever Nv Detergent compositions in tablet form and process for producing thereof
US6410500B1 (en) * 1997-12-30 2002-06-25 Henkel Kommanditgesellschaft Auf Aktien Moulded body dishwasher detergents with soil release polymers
EP1051476A1 (en) * 1998-01-26 2000-11-15 The Procter & Gamble Company Multi-layer detergent tablet
DE19803410A1 (en) * 1998-01-28 1999-07-29 Henkel Kgaa Multiphase laundry detergent tablets exhibiting high hardness and rapid disintegration
GB9802390D0 (en) * 1998-02-04 1998-04-01 Unilever Plc Detergent compositions
WO1999055818A1 (en) * 1998-04-27 1999-11-04 The Procter & Gamble Company Non-particulate detergent product containing bleach activator
DE19819187A1 (en) * 1998-04-30 1999-11-11 Henkel Kgaa Solid dishwasher detergent with phosphate and crystalline layered silicates
FR2778666B1 (en) * 1998-05-14 2003-01-17 Chimiotechnic THREE-LAYERED DETERGENT TABLET
WO2000004117A2 (en) * 1998-07-17 2000-01-27 The Procter & Gamble Company Detergent tablet
FR2781810B1 (en) * 1998-07-31 2000-09-15 Chimiotechnic MULTI-LAYER DETERGENT TABLET FOR WASHING LAUNDRY AND METHOD OF MANUFACTURE
US6686329B1 (en) * 1998-08-13 2004-02-03 The Procter & Gamble Company Multilayer detergent tablet with different hardness
EP0979862A1 (en) * 1998-08-13 2000-02-16 The Procter & Gamble Company Multilayer detergent tablet with different hardness
EP0979863A1 (en) * 1998-08-13 2000-02-16 The Procter & Gamble Company Multilayer detergent tablet with different elasticities
DE19845602A1 (en) * 1998-10-05 2000-04-06 Henkel Kgaa Detergent tab pack for dishwashers
EP1004661A1 (en) 1998-11-11 2000-05-31 DALLI-WERKE WÄSCHE- und KÖRPERPFLEGE GmbH & Co. KG High density granule, method for production thereof, and its use as disintegrant in tablets
ATE198348T1 (en) 1998-11-11 2001-01-15 Dalli Werke Waesche & Koerperp COMPACTED GRANULES, PRODUCTION PROCESS AND USE AS EXPLOSIVES FOR PRESSED MOLDINGS
US6974789B1 (en) * 1999-01-23 2005-12-13 The Procter & Gamble Company Detergent tablet
DE19908022A1 (en) * 1999-02-25 2000-08-31 Henkel Kgaa Storage-stable detergent tablets
US6630438B1 (en) * 1999-03-12 2003-10-07 The Procter & Gamble Company Perfumed detergent tablet
AU3290300A (en) * 1999-03-25 2000-10-16 Henkel Kommanditgesellschaft Auf Aktien Tablet containing a builder
PT1043391E (en) * 1999-03-29 2006-12-29 Dalli Werke Gmbh & Co Kg High density disintegrating granulate for tablets; method for making it and its use
EP1048717A1 (en) * 1999-04-30 2000-11-02 The Procter & Gamble Company Detergent compositions
EP1048719A1 (en) * 1999-04-30 2000-11-02 The Procter & Gamble Company Detergent compositions
EP1048714A1 (en) * 1999-04-30 2000-11-02 The Procter & Gamble Company Method of dispensing a detergent composition
EP1048712A1 (en) * 1999-04-30 2000-11-02 The Procter & Gamble Company A process of treating fabrics with a laundry detergent additive tablet
EP1048718A1 (en) * 1999-04-30 2000-11-02 The Procter & Gamble Company Detergent compositions
EP1048720A1 (en) * 1999-04-30 2000-11-02 The Procter & Gamble Company Detergent compositions
EP1048715A1 (en) * 1999-04-30 2000-11-02 The Procter & Gamble Company Method of dispensing a detergent composition
EP1048716A1 (en) * 1999-04-30 2000-11-02 The Procter & Gamble Company Detergent composition
GB9911949D0 (en) * 1999-05-21 1999-07-21 Unilever Plc Detergent compositions
GB9918020D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Detergent compositions
DE19943550A1 (en) * 1999-09-11 2001-03-15 Clariant Gmbh Highly alkaline crystalline sodium silicate
DE19943237A1 (en) * 1999-09-11 2001-05-17 Clariant Gmbh Cogranulates from layered alkali silicates and disintegrants
DE19943551A1 (en) * 1999-09-11 2001-03-15 Clariant Gmbh Poorly soluble alkali silicate
US6686327B1 (en) * 1999-10-09 2004-02-03 Cognis Deutschland Gmbh & Co. Kg Shaped bodies with improved solubility in water
DE19953792A1 (en) * 1999-11-09 2001-05-17 Cognis Deutschland Gmbh Detergent tablets
DE19961660A1 (en) * 1999-12-21 2001-07-12 Henkel Kgaa Care products for washing machines and dishwashers
US6407050B1 (en) 2000-01-11 2002-06-18 Huish Detergents, Inc. α-sulfofatty acid methyl ester laundry detergent composition with reduced builder deposits
DE10005575A1 (en) * 2000-02-09 2001-08-23 Reckitt Benckiser Nv Detergent composition in tablet form
DE10005574A1 (en) * 2000-02-09 2001-08-23 Reckitt Benckiser Nv Detergent composition in tablet form
US6566317B2 (en) * 2000-04-25 2003-05-20 Cognis Corporation Process for inhibiting gel formation of hydrated detergent tablets containing nonionic surfactant ethoxylates
US6780830B1 (en) * 2000-05-19 2004-08-24 Huish Detergents, Incorporated Post-added α-sulfofatty acid ester compositions and methods of making and using the same
US6683039B1 (en) 2000-05-19 2004-01-27 Huish Detergents, Inc. Detergent compositions containing alpha-sulfofatty acid esters and methods of making and using the same
US6534464B1 (en) 2000-05-19 2003-03-18 Huish Detergents, Inc. Compositions containing α-sulfofatty acid ester and polyalkoxylated alkanolamide and methods of making and using the same
US6509310B1 (en) 2000-06-01 2003-01-21 Huish Detergents, Inc. Compositions containing α-sulfofatty acid esters and method of making the same
GB0020379D0 (en) * 2000-08-21 2000-10-04 Clariant Int Ltd Enzyme composition in tablet form
DE10056346A1 (en) * 2000-11-14 2002-05-16 Clariant Gmbh Builders for use in detergents, washing agents and water-softeners show reduced amounts of residue on dissolving and are based on crystalline layered sodium silicates
US20030040459A1 (en) * 2001-02-05 2003-02-27 Unilever Home & Pesonal Care Usa Cleaning compositions
EP1354938A1 (en) * 2002-04-18 2003-10-22 Unilever N.V. Laundry tablets with improved dissolution behaviour
DE10257390A1 (en) * 2002-12-06 2004-06-24 Ecolab Gmbh & Co. Ohg Acidic cleaner in block form for preparation of aqueous cleaning solutions for cleaning surfaces in the institutional, industrial and agricultural sectors comprises less water
US6669929B1 (en) * 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
US6833085B2 (en) * 2003-02-10 2004-12-21 Kiyoharu Hamasaki Agent for restricting elution of phosphorus, method for producing the same, and method of restricting elution of phosphorus in sludge
DE602004018161D1 (en) 2003-07-28 2009-01-15 Mallinckrodt Inc IMPROVED STEARATE COMPOSITION AND MANUFACTURING METHOD THEREFOR
DE102004020009A1 (en) * 2004-04-21 2005-11-10 Henkel Kgaa Washing/cleaning agent molded article, useful as e.g. detergent tablets or water softener tablets, comprises dirt-removable cellulose derivative obtained by alkylation and hydroxyalkylation of cellulose
US20070148213A1 (en) * 2005-12-22 2007-06-28 Sayed Ibrahim Film containing compositions
US20090032063A1 (en) * 2007-07-30 2009-02-05 Haas Geoffrey R Solid cleaning composition and method of use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450494A (en) * 1967-07-18 1969-06-17 Conrad J Gaiser Amorphous sodium silicate having inherent binding properties and method of producing same
US4370250A (en) * 1976-12-06 1983-01-25 Colgate-Palmolive Company Detergent tablet
US4451386A (en) * 1976-12-06 1984-05-29 Colgate-Palmolive Company Detergent tablet
DE3413571A1 (en) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt USE OF CRYSTALLINE LAYERED SODIUM SILICATES FOR WATER SOFTENING AND METHOD FOR WATER SOFTENING
DE3634813A1 (en) * 1986-10-13 1988-04-14 Henkel Kgaa DETERGENT TABLETS FOR MACHINE DISHWASHER
DE3641314A1 (en) * 1986-12-03 1988-06-09 Henkel Kgaa LAUNDRY TREATMENT AGENT BASED ON LAYERED SILICATE
DE3706036A1 (en) * 1987-02-25 1988-09-08 Basf Ag POLYACETALS, METHOD FOR THE PRODUCTION THEREOF FROM DIALDEHYDES AND POLYOLCARBONIC ACIDS AND USE OF THE POLYACETALS
DE3827895A1 (en) * 1988-08-17 1990-02-22 Henkel Kgaa PROCESS FOR PREPARING PHOSPHATE-REDUCED DETERGENT TABLETS
YU221490A (en) * 1989-12-02 1993-10-20 Henkel Kg. PROCEDURE FOR HYDROTHERMAL PRODUCTION OF CRYSTAL SODIUM DISILICATE
DE3941365A1 (en) * 1989-12-15 1991-06-20 Henkel Kgaa METHOD FOR PRODUCING SALTS OF SULFATED FATTY ACID GLYCERINESTER
US5071587A (en) * 1990-05-31 1991-12-10 Aquatechnica, Inc. Composition and method for purifying water
GB9015504D0 (en) * 1990-07-13 1990-08-29 Unilever Plc Detergents composition
DE4104085A1 (en) * 1991-02-11 1992-08-13 Henkel Kgaa GRANULAR ADDITIVE FOR DETERGENT AND CLEANING AGENT
DK166548B1 (en) * 1991-03-15 1993-06-07 Cleantabs As PHOSPHATE-FREE MACHINE DISHWASH
DK167363B1 (en) * 1991-04-12 1993-10-18 Cleantabs As CLOTHING DETERGENT
US5540855A (en) * 1991-04-23 1996-07-30 The Procter & Gamble Company Particulate detergent compositions
EP0525239B1 (en) * 1991-07-31 1997-07-09 AUSIMONT S.p.A. Process for increasing the bleaching efficiency of an inorganic persalt
DE4127323A1 (en) * 1991-08-20 1993-02-25 Henkel Kgaa METHOD FOR PRODUCING TENSIDE GRANULES
DE4134914A1 (en) * 1991-10-23 1993-04-29 Henkel Kgaa DETERGENT AND CLEANING AGENT WITH SELECTED BUILDER SYSTEMS
DE4203923A1 (en) * 1992-02-11 1993-08-12 Henkel Kgaa METHOD FOR PRODUCING POLYCARBOXYLATES ON A POLYSACCHARIDE BASE
DE4300772C2 (en) * 1993-01-14 1997-03-27 Stockhausen Chem Fab Gmbh Water-soluble, biodegradable copolymers based on unsaturated mono- and dicarboxylic acids, process for their preparation and their use
DE4318902C2 (en) * 1993-06-07 1996-10-24 Benckiser Gmbh Joh A Water-soluble, water-softening agent
DE4400024A1 (en) * 1994-01-03 1995-07-06 Henkel Kgaa Silicate builders and their use in detergents and cleaning agents as well as multi-component mixtures for use in this field
ES2201162T3 (en) * 1995-04-12 2004-03-16 Cleantabs A/S COMPRESSED FROM WHITENING AGENTS.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9521908A1 *

Also Published As

Publication number Publication date
DE59509220D1 (en) 2001-05-31
US5900399A (en) 1999-05-04
EP0743978B1 (en) 2001-04-25
DE4404279A1 (en) 1995-08-17
EP0965565A1 (en) 1999-12-22
ATE200794T1 (en) 2001-05-15
ES2157320T3 (en) 2001-08-16
WO1995021908A1 (en) 1995-08-17

Similar Documents

Publication Publication Date Title
EP0743978B1 (en) Bleaching tablet with builder substances
EP0777721B1 (en) Process for producing tablets of washing or cleaning agents
EP0738237B1 (en) Silicate builders and their use in washing or cleaning agents and multi-substance mixtures for use in this field
DE4112075C2 (en)
DE19710254A1 (en) Shaped or active cleaning moldings for household use
DE3827895A1 (en) PROCESS FOR PREPARING PHOSPHATE-REDUCED DETERGENT TABLETS
EP1043389B1 (en) Detergent tablets containing a granular disintegrant
EP0591282A1 (en) Method for the production of cleaing-agent tablets for machine dishwashing.
WO1998055575A1 (en) Additive granules for moulded bodies having a detergent and cleaning action
WO1991015568A1 (en) Stable, bifunctional, phosphate-free detergent tablets for use in dishwashing machines
WO1994018295A1 (en) Builder for detergents or cleansers
EP0888449B1 (en) Solid surfactant and builder-containing washing and cleaning agent with a high bulk density or compound for such an agent
WO1998054283A1 (en) Detergent shaped body with enhanced dissolving properties
EP1043388B1 (en) Machine dishwashing tablets containing a granular disintegrant
EP0748369A1 (en) Multi-substance mixtures based on water-soluble alkali silicate compounds and their use
EP0877791B1 (en) Process for the preparation of moulded bodies consisting of a washing or cleaning agent
DE19637606A1 (en) Detergent tablets combining good dissolution properties with breaking resistance
DE10123621B4 (en) Process for the preparation of a water softener tablet
WO2000058435A1 (en) Tablet containing a builder
EP1141191B1 (en) Phosphate compounds
DE19942796A1 (en) Tablet containing builder

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960801

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE DE ES FR GB IT NL

17Q First examination report despatched

Effective date: 19990701

RTI1 Title (correction)

Free format text: BLEACHING TABLET WITH BUILDER SUBSTANCES

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE DE ES FR GB IT NL

REF Corresponds to:

Ref document number: 200794

Country of ref document: AT

Date of ref document: 20010515

Kind code of ref document: T

REF Corresponds to:

Ref document number: 59509220

Country of ref document: DE

Date of ref document: 20010531

ITF It: translation for a ep patent filed

Owner name: STUDIO JAUMANN P. & C. S.N.C.

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20010725

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2157320

Country of ref document: ES

Kind code of ref document: T3

EN Fr: translation not filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

EN Fr: translation not filed

Free format text: BO 01/38 PAGES: 263, IL Y A LIEU DE SUPPRIMER: LA MENTION DE LA NON REMISE. LA REMISE EST PUBLIEE DANS LE PRESENT BOPI

ET Fr: translation filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020228

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
BERE Be: lapsed

Owner name: HENKEL K.G.A.A.

Effective date: 20020228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20020901

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20020901

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20060126

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20060201

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20060213

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20060220

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20060228

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20060317

Year of fee payment: 12

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20070201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070201

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20071030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070201

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070228

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20070202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070202

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070201